<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neuronal Signal</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuronal Signal</journal-id>
<journal-id journal-id-type="publisher-id">ns</journal-id>
<journal-title-group>
<journal-title>Neuronal Signaling</journal-title>
</journal-title-group>
<issn pub-type="epub">2059-6553</issn>
<publisher>
<publisher-name>Portland Press Ltd.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32714579</article-id>
<article-id pub-id-type="pmc">7373246</article-id>
<article-id pub-id-type="doi">10.1042/NS20160010</article-id>
<article-id pub-id-type="publisher-id">NS20160010</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Bases of Health &amp; Disease</subject>
</subj-group>
<subj-group subj-group-type="toc-heading">
<subject>Review Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>SUMOylation and calcium signalling: potential roles in the brain and beyond</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Coelho-Silva</surname>
<given-names>Leticia</given-names>
</name>
<xref ref-type="aff" rid="AFF1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stephens</surname>
<given-names>Gary J.</given-names>
</name>
<xref ref-type="aff" rid="AFF2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cimarosti</surname>
<given-names>Helena</given-names>
</name>
<email>helena.cimarosti@ufsc.br</email>
<xref ref-type="aff" rid="AFF1"></xref>
<xref ref-type="corresp" rid="COR1"></xref>
</contrib>
</contrib-group>
<aff id="AFF1"><label>1</label>Department of Pharmacology, Federal University of Santa Catarina, Florianopolis, Brazil</aff>
<aff id="AFF2"><label>2</label>School of Pharmacy, University of Reading, Reading, U.K.</aff>
<author-notes>
<corresp id="COR1"><bold>Correspondence:</bold> Helena Cimarosti (<email>helena.cimarosti@ufsc.br</email>)</corresp>
</author-notes>
<pub-date pub-type="collection">
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>7</month>
<year>2017</year>
</pub-date>
<volume>1</volume>
<issue>3</issue>
<elocation-id>NS20160010</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>10</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="accepted-manuscript">
<day>12</day>
<month>7</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 The Author(s).</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).</license-p>
</license>
</permissions>
<self-uri xlink:href="ns-01-ns20160010.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Small ubiquitin-like modifier (SUMO) conjugation (or SUMOylation) is a post-translational protein modification implicated in alterations to protein expression, localization and function. Despite a number of nuclear roles for SUMO being well characterized, this process has only started to be explored in relation to membrane proteins, such as ion channels. Calcium ion (Ca<sup>2+</sup>) signalling is crucial for the normal functioning of cells and is also involved in the pathophysiological mechanisms underlying relevant neurological and cardiovascular diseases. Intracellular Ca<sup>2+</sup> levels are tightly regulated; at rest, most Ca<sup>2+</sup> is retained in organelles, such as the sarcoplasmic reticulum, or in the extracellular space, whereas depolarization triggers a series of events leading to Ca<sup>2+</sup> entry, followed by extrusion and reuptake. The mechanisms that maintain Ca<sup>2+</sup> homoeostasis are candidates for modulation at the post-translational level. Here, we review the effects of protein SUMOylation, including Ca<sup>2+</sup> channels, their proteome and other proteins associated with Ca<sup>2+</sup> signalling, on vital cellular functions, such as neurotransmission within the central nervous system (CNS) and in additional systems, most prominently here, in the cardiac system.</p>
</abstract>
<kwd-group>
<kwd>Ca2+ channels</kwd>
<kwd>neurotransmission</kwd>
<kwd>post-translational protein modification</kwd>
<kwd>SUMO</kwd>
<kwd>SUMOylation</kwd>
</kwd-group>
<counts>
<page-count count="13"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="sec1" sec-type="intro">
<title>Introduction</title>
<p>The small ubiquitin-like modifier (SUMO) was first described as targeting nuclear proteins that regulate transcription factors, gene expression and DNA integrity [<xref ref-type="bibr" rid="B1">1</xref>]. Experiments with knockout mice for the sole SUMO conjugating enzyme, ubiquitin-like conjugating enzyme 9 (Ubc9), demonstrated nuclear dysfunction and embryonic lethality, confirming that SUMOylation is physiologically indispensable [<xref ref-type="bibr" rid="B2">2</xref>]. Reports that are more recent have shown that SUMO can also target cytosolic and membrane proteins, including ion channels, to regulate crucial cellular functions, such as plasma membrane depolarization and neurotransmission [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. So far, the majority of studies have focused on SUMOylation of potassium (K<sup>+</sup>) channels, which are involved in setting the duration and firing pattern of action potentials [<xref ref-type="bibr" rid="B5">5</xref>]. For example, SUMOylation can modulate both two-pore domain K<sup>+</sup> (K2P) channels [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B6">6</xref>–<xref ref-type="bibr" rid="B9">9</xref>], responsible for the regulation of background leak currents, and voltage-dependent K<sup>+</sup> (K<sub>V</sub>) channels [<xref ref-type="bibr" rid="B10">10</xref>–<xref ref-type="bibr" rid="B13">13</xref>] that repolarize cell membrane during action potential input. However, there is also recent evidence that voltage-gated Ca<sup>2+</sup> channels (VGCCs) [<xref ref-type="bibr" rid="B14">14</xref>] and transient receptor potential (TRP) channels [<xref ref-type="bibr" rid="B15">15</xref>], both of which can mediate Ca<sup>2+</sup> influx, are SUMO targets. Considering the utmost relevance of Ca<sup>2+</sup> in physiological and pathophysiological processes, and the growing evidence that SUMO can modify ion channels, our review focused on the potential roles of SUMOylation of Ca<sup>2+</sup> channels and proteins related with Ca<sup>2+</sup> signalling with a focus on the central nervous system (CNS) and, also, the cardiac system.</p>
</sec>
<sec id="sec2">
<title>SUMOylation pathways</title>
<p>Post-translational modifications of proteins can affect their function, localization and degradation depending on the stimulus applied, to control cellular response [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. SUMOylation is a reversible lysine-targeted post-translational modification, whereby covalently conjugated SUMO regulates proteins in numerous pathways [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. Currently, there are five proposed SUMO isoforms, with SUMO-1, 2 and 3 being the best-characterized paralogs. SUMO-1 shares approximately 50% of its amino acid sequence with both SUMO-2 and SUMO-3, which are typically known as SUMO-2/3 since they differ by only three N-terminal amino acids and antibodies are usually unable to distinguish between them [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. Despite the similarities, there are functional differences between SUMO-1 and SUMO-2/3. For instance, under basal conditions, unconjugated SUMO-1 is scarce, but free SUMO-2/3 is widely expressed in mammalian cells [<xref ref-type="bibr" rid="B22">22</xref>]. Although the exact role for SUMO-4 remains uncertain, it has been associated with the pathophysiological mechanisms underlying diabetes [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. Finally, the existence of a fifth SUMO isoform, SUMO-5, that regulates promyelocytic leukaemia nuclear bodies, has recently been suggested [<xref ref-type="bibr" rid="B25">25</xref>]. The same enzymes conjugate all SUMO isoforms [<xref ref-type="bibr" rid="B19">19</xref>].</p>
<p>The first step in the SUMOylation process requires the maturation of SUMO by SUMO-specific isopeptidases/proteases; next, SUMO is activated in an ATP-dependent step by E1 complex, which in humans consists of an heterodimer formed by SUMO-activating enzyme subunits 1 and 2 (SAE1 and SAE2 respectively). Subsequently, SUMO is transferred from the E1 activating enzyme to the E2 conjugating enzyme, also known as Ubc9, which is able to conjugate SUMO to target proteins both in E3 ligase-dependent and -independent manners. Most target proteins carry the same consensus motif that is directly recognized by Ubc9: the –K–x–D/E sequence, with representing a large hydrophobic residue (commonly isoleucine, leucine or valine), K is the modified lysine, x is any residue and D/E are acidic residues [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. Nevertheless, non-covalent interactions between SUMO and target proteins can occur through SUMO interacting motifs (SIMs) [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. These SIMs consist of a short stretch of branched hydrophobic residues, typically comprising isoleucine (I) or valine (V) residues organized as (V/I)–x–(V/I)–(V/I) or (V/I)–(V/I)–x–(V/I), flanked NH<sub>2</sub>– or COOH– terminally by serine residues and/or acidic residues [<xref ref-type="bibr" rid="B28">28</xref>]. Alternatively, SUMO E3 ligases can directly bind to target proteins [<xref ref-type="bibr" rid="B17">17</xref>]. The SUMOylation process is highly reversible by the same enzymes responsible for SUMO maturation and also SUMO deconjugation from substrate proteins [<xref ref-type="bibr" rid="B29">29</xref>].</p>
<p>Recently, three distinct families of SUMO-specific isopeptidases and proteases have been identified in mammals: the ubiquitin-like protease/sentrin-specific protease (Ulp/SENP), the deSUMOylating isopeptidase (Desi) and ubiquitin-specific peptidase-like protein 1 (USPL1) [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>]. The SENPs are the best characterized and, so far, six SENP isoforms have been identified in humans: SENP1, 2, 3, 5, 6 and 7 [<xref ref-type="bibr" rid="B17">17</xref>]. SENP1 is highly expressed in the nucleus, in the nuclear pore and as discrete nuclear ‘dots’ [<xref ref-type="bibr" rid="B32">32</xref>], but can also be found in all neuronal processes and at synapses at lower levels [<xref ref-type="bibr" rid="B33">33</xref>–<xref ref-type="bibr" rid="B35">35</xref>]. During the maturation phase, SENP1 cleaves pro-SUMO preferentially to generate SUMO-1 and SUMO-2/3 [<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref>], while it deconjugates both SUMO isoforms [<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. SENP2 is similar to SENP1 with respect to its localization and characteristics regarding the maturation step, but differs from SENP1 regarding its highly selectivity for SUMO-2/3 deconjugation [<xref ref-type="bibr" rid="B37">37</xref>–<xref ref-type="bibr" rid="B40">40</xref>]. SENP3 is found in the nucleus, but also in the mitochondria and participates in neuronal signalling [<xref ref-type="bibr" rid="B41">41</xref>]. The role of SENP3 in cleaving pro-SUMO has not been elucidated as yet, but it is suggested that SENP3 is somehow selective for removing SUMO-2/3 from target proteins [<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. As for SENP3, SENP5 has a nuclear localization [<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B42">42</xref>] and is important for SUMO-2/3 maturation and deconjugation [<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B43">43</xref>]. Finally, SENP6 and SENP7 are located throughout the nucleoplasm [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B44">44</xref>] and, although neither participates in the maturation step, they are both important for removal of SUMO-2/3 [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B45">45</xref>]. Regarding the Desi family, two isoforms have been identified so far: Desi-1 and Desi-2. Whereas Desi-1 is found both in the cytoplasm and the nucleus, where it promotes deconjugation of all SUMO isoforms, Desi-2 is exclusively cytoplasmatic and its properties remain undefined [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>]. Lastly, USPL1 preferably promotes SUMO-2/3 deconjugation and is located in Cajal bodies [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>].</p>
</sec>
<sec id="sec3">
<title>Roles of SUMOylation in neurological diseases</title>
<p>Disruption of basal SUMOylation has been implicated in multiple neurological disorders, including neurodegenerative diseases, such as Alzheimer and Parkinson’s diseases (AD and PD respectively), spinocerebellar ataxias (SCAs), cerebral ischaemia and epilepsy [<xref ref-type="bibr" rid="B46">46</xref>]. More specifically, amyloid precursor protein (APP) and tau, which are key proteins in AD, have been identified as SUMO targets in HeLa and HEK293 cells [<xref ref-type="bibr" rid="B47">47</xref>–<xref ref-type="bibr" rid="B49">49</xref>]. APP undergoes proteolytic cleavage by α- or β-secretases, and both are followed by further γ-secretase processing [<xref ref-type="bibr" rid="B50">50</xref>]. While α-secretases cleave APP to peptides that are proposed to participate in neuroprotection and neuroplasticity, characterizing the non-amyloidogenic pathway [<xref ref-type="bibr" rid="B51">51</xref>], cleavage by β-secretases leads to the amyloidogenic pathway, generating toxic amyloid β (Aβ) that accumulates and forms amyloid plaques [<xref ref-type="bibr" rid="B52">52</xref>]. A reduction in Aβ aggregates was found in HeLa cells when APP was SUMOylated by either SUMO-1 or SUMO-2 at lysines 587 and 595, which are located adjacently to the β-secretase site [<xref ref-type="bibr" rid="B48">48</xref>]. Moreover, poly-SUMOylation of APP by SUMO-3 has been reported to regulate APP cleavage and decrease Aβ production in HEK293 cells [<xref ref-type="bibr" rid="B53">53</xref>]. Conversely, SUMO-3, as well as SUMO-1, was found to increase γ-secretase levels [<xref ref-type="bibr" rid="B54">54</xref>], thus increasing Aβ production in a transgenic mice model for AD [<xref ref-type="bibr" rid="B55">55</xref>]. It is important to note that SUMO-3 effects on Aβ deposition might not be dependent on the ability of SUMO-3 to conjugate to target proteins [<xref ref-type="bibr" rid="B54">54</xref>]. Another AD hallmark is the hyperphosphorylation of tau [<xref ref-type="bibr" rid="B56">56</xref>] that decreases its affinity for microtubules, resulting in tau accumulation and formation of neurofibrillary tangles [<xref ref-type="bibr" rid="B57">57</xref>]. Tau can undergo SUMOylation at lysine 340 in HEK293 cells, which triggered its phosphorylation and inhibited its degradation by the ubiquitin–proteasome pathway, thus increasing tau aggregation [<xref ref-type="bibr" rid="B47">47</xref>].</p>
<p>As for mouse models of AD [<xref ref-type="bibr" rid="B55">55</xref>], increased levels of SUMO-1 were found in the plasma of patients with dementia [<xref ref-type="bibr" rid="B58">58</xref>]. Conversely, SUMO-1 conjugates were not altered in the post-mortem hippocampus of AD patients, whereas SUMO-2/3 high molecular weight conjugates were decreased [<xref ref-type="bibr" rid="B59">59</xref>]. These observations are in agreement with previous reports that found increased SUMO-1 and decreased SUMO-2 conjugation levels in the cortex and hippocampus respectively, of Tg2576 mice [<xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B61">61</xref>]. However, a recent study demonstrated absence of gross changes in global SUMOylation levels in the post-mortem cortex of AD patients [<xref ref-type="bibr" rid="B62">62</xref>].</p>
<p>α-Synuclein, parkin and DJ-1 are examples of SUMO targets relevant to PD [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B63">63</xref>,<xref ref-type="bibr" rid="B64">64</xref>]. Cytosolic inclusions known as Lewy bodies, comprised mostly by aggregated α-synuclein, contribute to the synaptic dysfunction and consequent dopaminergic neuronal death predominantly in the substantia nigra, a well-described characteristic of PD [<xref ref-type="bibr" rid="B65">65</xref>–<xref ref-type="bibr" rid="B68">68</xref>]. Promisingly, SUMO-1 conjugation to α-synuclein reduced its aggregation and toxicity in a transgenic mice model for PD [<xref ref-type="bibr" rid="B69">69</xref>]. Interestingly, in an early communication, lysosomal SUMO-1 labelling was identified in human olfactory mucosa-neurospheres obtained from biopsies of patients with idiopathic PD [<xref ref-type="bibr" rid="B70">70</xref>]. A similar finding was observed in post-mortem tissue from patients with multiple system atrophy and progressive supranuclear palsy, diseases in which α-synuclein and tau seem to be involved [<xref ref-type="bibr" rid="B70">70</xref>,<xref ref-type="bibr" rid="B71">71</xref>]. In both familial and sporadic PD, parkin, which is an ubiquitin ligase, can be found together with α-synuclein in Lewy bodies, where SUMO-1 was shown to non-covalently and selectively interact with parkin, increasing its auto-ubiquitination and transportion to the nucleus [<xref ref-type="bibr" rid="B72">72</xref>]. Moreover, SUMOylation of DJ-1, a transcriptional regulator mutated in 1–2% of early-onset PD cases, maintained its cytoprotective function in response to oxidative stress [<xref ref-type="bibr" rid="B73">73</xref>,<xref ref-type="bibr" rid="B74">74</xref>], whereas incomplete SUMOylation of DJ-1 led to its proteasomal degradation [<xref ref-type="bibr" rid="B75">75</xref>]. In a similar way to SUMOylated α-synuclein, increased SUMO conjugation to ataxin-7 decreased its aggregation and cytotoxicity in SCAs [<xref ref-type="bibr" rid="B76">76</xref>].</p>
<p>Despite several reports from our group and others showing that SUMOylation can protect cells from metabolic stress caused by low levels of oxygen and glucose in different models of cerebral ischaemia and hypoxic conditions [<xref ref-type="bibr" rid="B77">77</xref>–<xref ref-type="bibr" rid="B81">81</xref>], disease-modified SUMO targets remain largely unknown. However, one such target is the mitochondrial GTPase dynamin-related protein 1 (Drp1), which regulates mitochondrial fission [<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B82">82</xref>]. Under stress conditions, Drp1-mediated mitochondrial fission can release cytochrome <italic>c</italic> and induce caspase cleavage followed by cell apoptosis [<xref ref-type="bibr" rid="B83">83</xref>]. In an <italic>in vitro</italic> model of ischaemia, oxygen and glucose deprivation led to SENP3 degradation and consequent increase in SUMO-2/3 conjugation to Drp1, thus preventing mitochondrial fission and cytochrome <italic>c</italic> release, as well as promoting cell survival [<xref ref-type="bibr" rid="B41">41</xref>]. Another ischaemia-modified SUMO target is the isoform 3 of the sodium (Na<sup>+</sup>)/Ca<sup>2+</sup> exchanger (NCX), which controls ionic homoeostasis during cerebral ischaemia [<xref ref-type="bibr" rid="B84">84</xref>]. NCX3 f-loop lysine 590 is required for SUMOylation, and the absence of this residue increased NCX3 degradation, exacerbating ischaemic damage induced by permanent and transient middle cerebral artery occlusion (MCAO) [<xref ref-type="bibr" rid="B85">85</xref>]. Following preconditioning and transient MCAO, SUMO-1 basal expression led to increased NCX3 levels, whereas SUMO silencing decreased NCX3 levels, suggesting that NCX3 SUMOylation participates in the protective role that SUMO-1 plays during ischaemic preconditioning [<xref ref-type="bibr" rid="B85">85</xref>].</p>
<p>Evidence shows that SUMOylation may be involved in mechanisms implicated in the development and maintenance of epilepsy, since it was demonstrated that neuronal K<sup>+</sup> channels could be SUMOylated, thus modulating neuronal excitability [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B6">6</xref>–<xref ref-type="bibr" rid="B10">10</xref>]. Moreover, SUMOylation of excitatory receptor subunits can modulate receptor trafficking and interfere with synaptic transmission [<xref ref-type="bibr" rid="B86">86</xref>–<xref ref-type="bibr" rid="B90">90</xref>]. For example, SUMOylation of the GluK2 subunit of kainate receptors led to receptor internalization, which could be neuroprotective against excitotoxicity [<xref ref-type="bibr" rid="B33">33</xref>]. More recently, the major cause of premature death in epilepsy, known as sudden unexplained death in epilepsy, has been linked with the hyper-SUMOylation of the K<sub>V</sub>7 K<sup>+</sup> channel, which functionally reduces the depolarizing M-current conducted by this channel [<xref ref-type="bibr" rid="B13">13</xref>].</p>
</sec>
<sec id="sec4">
<title>Ca<sup>2+</sup> channels</title>
<p>Unique amongst other ions, Ca<sup>2+</sup> can modulate both membrane potential and function as an important signalling entity. Several cellular processes, ranging from neurotransmitter/hormone release [<xref ref-type="bibr" rid="B91">91</xref>] and muscle contraction [<xref ref-type="bibr" rid="B92">92</xref>] to gene transcription [<xref ref-type="bibr" rid="B93">93</xref>,<xref ref-type="bibr" rid="B94">94</xref>], require an increase in the intracellular Ca<sup>2+</sup> levels, which under basal conditions are maintained approximately 100 nM [<xref ref-type="bibr" rid="B95">95</xref>]. This temporary increase occurs by either release from intracellular Ca<sup>2+</sup> stores or influx into the cell by agonist-operated channels, G-protein coupled receptors, store-operated channels and, predominantly, through VGCCs located at the plasma membrane [<xref ref-type="bibr" rid="B96">96</xref>].</p>
<p>VGCCs were initially classified based on their voltage-dependent activation (high or low voltage-activated channels) [<xref ref-type="bibr" rid="B97">97</xref>,<xref ref-type="bibr" rid="B98">98</xref>] and subsequently subdivided by pharmacological and biophysical function (high voltage-activated and low voltage-activated) [<xref ref-type="bibr" rid="B99">99</xref>] and then by Ca<sub>V</sub>α1 subunits [<xref ref-type="bibr" rid="B100">100</xref>]. Ca<sub>V</sub>α1 structure allows selectivity for Ca<sup>2+</sup> over monovalent ions and contains a sensor motif that detects membrane depolarization leading to channel opening [<xref ref-type="bibr" rid="B96">96</xref>]. Based on their Ca<sub>V</sub>α1 subunits, three families of VGCCs have been defined: Ca<sub>V</sub>1 – present mainly in skeletal muscle, heart, neurons and endocrine cells, Ca<sub>V</sub>2 – found mainly at presynaptic terminals in the CNS, but also in peripheral synapses, and Ca<sub>V</sub>3 – localized mainly in the sinoatrial node, adrenal glomerulosa cells, neurons and sperm acrosome [<xref ref-type="bibr" rid="B100">100</xref>,<xref ref-type="bibr" rid="B101">101</xref>]. Ca<sub>V</sub>1 subunits form L-type Ca<sup>2+</sup> current; Ca<sub>V</sub>2.1 forms P/Q-type, Ca<sub>V</sub>2.2 N-type and Ca<sub>V</sub>2.3 form R-type current, whereas Ca<sub>V</sub>3 subunits form T-type current. In addition to the three Ca<sub>V</sub>α1 family subunits (Ca<sub>V</sub>1, Ca<sub>V</sub>2 and Ca<sub>V</sub>3), there are auxiliary β, α2, δ and also γ subunits that comprise the channel complex and have various functions including transporting channels from the endoplasmic reticulum to the plasma membrane, maintaining channel stability and contributing to physiological and pharmacological properties [<xref ref-type="bibr" rid="B100">100</xref>].</p>
</sec>
<sec id="sec5">
<title>Roles of Ca<sup>2+</sup> channels in neurological disorders</title>
<p>Pathological changes in Ca<sup>2+</sup> homoeostasis and deregulation of Ca<sup>2+</sup> channels are implicated in a range of neurological disorders, including epilepsy, cerebral ischaemia, pain, neurodegenerative, and psychiatric diseases [<xref ref-type="bibr" rid="B102">102</xref>–<xref ref-type="bibr" rid="B104">104</xref>]. Ca<sup>2+</sup> levels control neuronal hyperexcitability and mutations in VGCCs have been identified in familial CNS diseases (so-called ‘channelopathies’). For example, Ca<sub>V</sub>2.1 and Ca<sub>V</sub>3.2 channelopathies have been widely associated with forms of absence epilepsy and episodic ataxia [<xref ref-type="bibr" rid="B105">105</xref>]. Furthermore, acquired epilepsy and cerebral ischaemia can occur due to insults resulting from increased Ca<sup>2+</sup> influx [<xref ref-type="bibr" rid="B105">105</xref>,<xref ref-type="bibr" rid="B106">106</xref>]. Moreover, exocytosis of synaptic vesicles mediated by VGCCs, whereby membrane depolarization triggered by action potentials causes transmitter release, may be targeted in pain pathways, in particular at central terminals of sensory nociceptive afferents. For example, both Ca<sub>V</sub>2.2 and Ca<sub>V</sub>3.2 channels are crucial for control of neurotransmitter release at the dorsal horn [<xref ref-type="bibr" rid="B107">107</xref>,<xref ref-type="bibr" rid="B108">108</xref>]. Ca<sub>V</sub>2.2 is targeted therapeutically by ziconotide [<xref ref-type="bibr" rid="B109">109</xref>,<xref ref-type="bibr" rid="B110">110</xref>], a drug used to treat cancer-derived pain, and other drugs targeting Ca<sub>V</sub>2.2 are in development [<xref ref-type="bibr" rid="B96">96</xref>]. Ca<sub>V</sub>3.2 also acts to regulate afferent fibre excitability [<xref ref-type="bibr" rid="B111">111</xref>] and there is good evidence that these channels are up-regulated under chronic pain conditions [<xref ref-type="bibr" rid="B112">112–115</xref>].</p>
<p>Neurodegenerative diseases and psychiatric disorders have been related to Ca<sup>2+</sup> handling often with respect to mitochondrial function, since rises in Ca<sup>2+</sup> levels lead to mitochondrial stress and generation of reactive oxygen species [<xref ref-type="bibr" rid="B96">96</xref>]. In AD, deregulation of Ca<sup>2+</sup> homoeostasis contributes to Aβ production and accumulated Aβ interferes with Ca<sup>2+</sup> influx. Under physiological conditions, Ca<sup>2+</sup> entry is reported to contribute to APP cleavage by α-secretase, while improper intracellular Ca<sup>2+</sup> mobilization can affect APP processing and lead to increased Aβ levels, neuroinflammation and metabolic stress [<xref ref-type="bibr" rid="B115">115</xref>,<xref ref-type="bibr" rid="B116">116</xref>]. Aβ is proposed to modulate Ca<sup>2+</sup> influx in various ways including: by direct effects of oligomeric Aβ on the Ca<sub>V</sub>α1 subunit [<xref ref-type="bibr" rid="B117">117</xref>,<xref ref-type="bibr" rid="B118">118</xref>], inducing membrane-associated oxidative stress or contributing to excitotoxicity [<xref ref-type="bibr" rid="B116">116</xref>,<xref ref-type="bibr" rid="B119">119</xref>]. Moreover, mutations in Ca<sub>V</sub>1.2 and Ca<sub>V</sub>β2 have been linked to both bipolar disorder and schizophrenia, while mutations in Ca<sub>V</sub>1.3 have also been linked to bipolar disorder [<xref ref-type="bibr" rid="B96">96</xref>]. In addition, Ca<sub>V</sub>1.3 contributed to neuronal loss in PD as a consequence of inherent voltage-dependent activation of the subunit, rather than their selectivity for Ca<sup>2+</sup> [<xref ref-type="bibr" rid="B120">120</xref>]. Moreover, α-synuclein aggregation can modulate the influx of Ca<sup>2+</sup>, and, in turn, increases in Ca<sup>2+</sup> concentration can promote α-synuclein aggregation [<xref ref-type="bibr" rid="B121">121</xref>,<xref ref-type="bibr" rid="B122">122</xref>].</p>
</sec>
<sec id="sec6">
<title>SUMOylation and Ca<sup>2+</sup> signalling in neurotransmission</title>
<p>SUMOylation of proteins involved in Ca<sup>2+</sup> signalling affects the maintenance of neurotransmission from synapse formation (<xref ref-type="fig" rid="F1">Figure 1</xref>A) to neurotransmitter release (<xref ref-type="fig" rid="F1">Figure 1</xref>B) and synaptic plasticity. Mutations in the <italic>CACNA1A</italic> gene, which encodes the Ca<sub>V</sub>2.1 subunit, are found in SCA type 6 (SCA6) and lead to impaired VGCC function [<xref ref-type="bibr" rid="B123">123</xref>]. In an early communication, SUMO-1 overexpression was reported to decrease wild-type Ca<sub>V</sub>2.1 current density in HEK293 cells, whereas it had no effects on SCA6 Ca<sub>V</sub>2.1 mutants [<xref ref-type="bibr" rid="B124">124</xref>]. Interestingly, either SUMO-1 overexpression or SENP1 silencing enhanced cAMP-dependent exocytosis and glucagon secretion from both mouse and human pancreatic α-cells via effects on Ca<sub>V</sub>1 channels [<xref ref-type="bibr" rid="B14">14</xref>].</p>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<title>Potential roles played by SUMO on Ca<sup>2+</sup> signalling in neurotransmission</title>
<p>(<bold>A</bold>) Decreased calcium signalling leads to phosphorylation and SUMOylation of MEF2A, thus promoting synapse formation. As a result of VGCC activation, MEF2 is dephosphorylated and switches SUMOylation to acetylation inhibiting synaptic processes. (<bold>B</bold>) SUMOylated RIM1α facilitates the clustering of Ca<sub>V</sub>2.1 Ca<sup>2+</sup> channels and enhances Ca<sup>2+</sup> influx necessary for vesicular release. When SUMO is conjugated to CRMP2, it inhibits Ca<sup>2+</sup> entry through Ca<sub>V</sub>2.2 channels, and increases surface expression of Na<sub>V</sub>1.7 channels. SUMOylation of syntaxin-1A, synaptotagmin-1 and synapsin la can regulate neurotransmission by participating in docking/priming of synaptic vesicles; CRMP2, collapsin response mediator protein 2; MEF2, myocyte enhancer factor 2.</p>
</caption>
<graphic xlink:href="ns-01-ns20160010-g1"></graphic>
</fig>
<p>Increased SUMO-1 conjugation to presynaptic target proteins was shown to regulate Ca<sup>2+</sup> influx and neurotransmitter release in synaptosomes [<xref ref-type="bibr" rid="B125">125</xref>]. Depending on the applied stimulus, SUMOylation of presynaptic proteins could either increase or decrease neurotransmitter release. For example, loading synaptosomes with SUMO-1 and SENP1 peptides decreased and increased Ca<sup>2+</sup> influx and KCl-evoked glutamate release respectively. Conversely, kainate-induced Ca<sup>2+</sup> influx and neurotransmitter release were increased in synaptosomes loaded with SUMO-1 and decreased in synaptosomes loaded with SENP1 [<xref ref-type="bibr" rid="B125">125</xref>]. These results suggest that SUMO may be conjugated to distinct presynaptic proteins and act in an activity-dependent and stimulus-specific manner to modulate presynaptic release.</p>
<p>Crucial proteins in neurotransmitter release, CRMP2 and Rab3a-interacting molecule (RIM) have been identified as members of the Ca<sub>V</sub>2 proteome [<xref ref-type="bibr" rid="B126">126</xref>]. SUMOylation of VGCC interacting proteins has been reported to play an important role in neurotransmission within pain pathways. CRMP2 interacts with Ca<sub>V</sub>2.2 subunits in sensory neurons or nociceptors to modulate neurotransmitter release [<xref ref-type="bibr" rid="B127">127</xref>]. SUMO-1–3 modified CRMP2 at lysine 374 in cultured cathecholamine A differentiated cells [<xref ref-type="bibr" rid="B128">128</xref>]. Overexpression of SUMO, Ubc9 and CRMP2 in adult dorsal root ganglion neurons decreased, whereas overexpression of non-SUMOylatable CRMP2 increased, KCl depolarization-induced Ca<sup>2+</sup> entry. In addition, CRMP2 SUMOylation increased surface expression of Na<sub>V</sub>1.7 channels [<xref ref-type="bibr" rid="B129">129</xref>]. Mutations in Na<sub>V</sub>1.7 channels, which are highly expressed in peripheral sensory neurons, where they are responsible for regulating neuronal excitability, are directly related with pain disorders [<xref ref-type="bibr" rid="B130">130</xref>].</p>
<p>RIM1α interacts either directly or indirectly with most presynaptic active zone proteins and participates in the docking and priming of synaptic vesicles [<xref ref-type="bibr" rid="B131">131</xref>] by modulating Ca<sup>2+</sup> influx through regulation of VGCCs clustering [<xref ref-type="bibr" rid="B132">132</xref>,<xref ref-type="bibr" rid="B133">133</xref>]. SUMO-1 conjugation to RIM1α at lysine 502 was shown to be crucial for normal presynaptic exocytosis in neurons [<xref ref-type="bibr" rid="B133">133</xref>]. Knockdown of endogenous RIM1α, and its replacement with a non-SUMOylatable mutant, led to impairment of Ca<sup>2+</sup>-induced depolarization and consequent removal of the fast component of vesicle exocytosis. SUMOylated RIM1α facilitated the clustering of Ca<sub>V</sub>2.1 channels and enhanced Ca<sup>2+</sup> influx necessary for vesicular release, whereas de-SUMOylated RIM1α participated in the docking/priming of synaptic vesicles and structural maintenance of the active zone [<xref ref-type="bibr" rid="B133">133</xref>].</p>
<p>Presynaptic soluble <italic>N</italic>-ethylmaleimide sensitive factor attachment protein receptors (SNARE) proteins, such as syntaxin 1, are fundamental for neurotransmitter release [<xref ref-type="bibr" rid="B134">134</xref>] and might also participate in vesicle endocytosis [<xref ref-type="bibr" rid="B135">135</xref>,<xref ref-type="bibr" rid="B136">136</xref>]. Syntaxin 1A can be modified by SUMO-1 at any of three lysine residues (K252, K253 or K256) near the C-terminal transmembrane domain [<xref ref-type="bibr" rid="B137">137</xref>]. Preventing syntaxin 1A SUMOylation reduced its interaction with other SNARE proteins and disrupted the balance of synaptic vesicle endo/exocytosis, resulting in increased endocytosis. Another key protein that is SUMOylated is synapsin Ia: preventing SUMO-1 conjugation to synapsin Ia at lysine 687 caused impaired exocytosis due to a reduction in the number of releasable synaptic vesicles [<xref ref-type="bibr" rid="B138">138</xref>]. Proteomic analysis from a neuron-specific SUMO-1 overexpressing transgenic mouse model led to the identification of a number of previously unrecognized SUMO-1 targets <italic>in vivo</italic>, including the Ca<sup>2+</sup> sensor synaptotagmin-1 [<xref ref-type="bibr" rid="B139">139</xref>]. Increased SUMO-1 conjugation to synaptotagmin-1 resulted in impaired performed paired pulse facilitation (PPF), which involves the facilitation of neurotransmitter release caused by residual Ca<sup>2+</sup> from a previous stimulus.</p>
<p>Homologs of the SUMOylation machinery were identified in <italic>Drosophila</italic>, and an interaction with Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CaMKII) that modulates synaptic plasticity by regulating glutamatergic synapses [<xref ref-type="bibr" rid="B140">140</xref>] was demonstrated by yeast two-hybrid screening [<xref ref-type="bibr" rid="B141">141</xref>]. <italic>Drosophila</italic> SUMO-1 (DmSUMO-1) modification has potential to change the subcellular localization of CaMKII, but the functional consequences for this interaction remain to be confirmed.</p>
<p>Dendritic claws in cerebellar granular neurons, in which mossy fibre terminals and Golgi neurons form synapses [<xref ref-type="bibr" rid="B142">142</xref>], are regulated by the myocyte enhancer factor 2A (MEF2A). MEF2A transcription factor activity is regulated by several post-translational protein modifications, including phosphorylation [<xref ref-type="bibr" rid="B143">143</xref>–<xref ref-type="bibr" rid="B145">145</xref>], ubiquitination [<xref ref-type="bibr" rid="B146">146</xref>] and SUMOylation [<xref ref-type="bibr" rid="B147">147</xref>]. Lack of Ca<sup>2+</sup> signalling led to phosphorylation of MEF2A at serine 408, which in turn led to SUMO-1 conjugation at lysine 403 and inactivation of MEF2A, promoting dendritic claw differentiation, synapse formation and maturation. Activity-dependent Ca<sup>2+</sup> signalling via Ca<sub>V</sub>1 VGCCs induced calcineurin-mediated dephosphorylation of MEF2A at serine 408, promoting a switch from SUMOylation to acetylation at lysine 403, which in turn activated MEF2A and inhibited dendritic claw differentiation and synapse formation [<xref ref-type="bibr" rid="B147">147</xref>].</p>
<p>As previously described, deregulation of Ca<sup>2+</sup> homoeostasis contributes to aggregation of proteins such as Aβ and α-synuclein, known as aggregation-prone proteins, which can interfere with neurotransmission. Also, production and accumulation of these proteins interfere with Ca<sup>2+</sup> influx [<xref ref-type="bibr" rid="B148">148</xref>]. Two lysines of APP can be modified by SUMO <italic>in vivo</italic> leading to decreased levels of Aβ aggregates [<xref ref-type="bibr" rid="B48">48</xref>]. SUMOylation of α-synuclein seems to inhibit α-synuclein aggregation and toxicity both <italic>in vitro</italic> and <italic>in vivo</italic> [<xref ref-type="bibr" rid="B149">149</xref>]. This inhibition depends on the SUMO isoform (SUMO-1 conjugation is better than SUMO-3) and on the SUMOylated lysine (K102 is better than K96) [<xref ref-type="bibr" rid="B150">150</xref>]. Interestingly, raised concentrations of monomeric α-synuclein in the extracellular medium promoted dopamine release in the striatum via Ca<sub>V</sub>2.2 channels <italic>in vivo</italic> and <italic>in vitro</italic>, modifying plasma membrane structure and altering raft partitioning of this channel, suggesting the early reorganization of synaptic terminals as the mechanism to sensitizing dopaminergic neurons [<xref ref-type="bibr" rid="B151">151</xref>]. Paradoxically, SUMOylation of α-synuclein promoted its aggregation in COS-7 cells and had an intriguing protective effect [<xref ref-type="bibr" rid="B152">152</xref>].</p>
</sec>
<sec id="sec7">
<title>Roles of SUMOylation outside the brain and effects of SUMO on other channels</title>
<p>Other than the brain, SUMOylation is well characterized in the heart. Both Ubc9 inhibition and SUMO-2 knockout caused early embryonic lethality in mice [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B153">153</xref>], whereas SUMO-1 knockout led to specific cardiac septal defects [<xref ref-type="bibr" rid="B154">154</xref>]. Activating the SUMOylation pathway can also evoke cardiac abnormalities, such as cardiac specific SUMO-2 overexpression that induced premature death and severe cardiomyopathy [<xref ref-type="bibr" rid="B155">155</xref>]. Conversely, SUMO-1 overexpression improved heart failure [<xref ref-type="bibr" rid="B154">154</xref>–<xref ref-type="bibr" rid="B156">156</xref>], suggesting that tightly regulated SUMOylation levels are essential for normal cardiac development [<xref ref-type="bibr" rid="B154">154</xref>,<xref ref-type="bibr" rid="B157">157</xref>].</p>
<p>SUMOylation also influences cardiac metabolism, controlling crucial proteins for the maintenance of cardiac energy homoeostasis and mitochondrial biogenesis, such as peroxisome proliferator-activated receptor (PPAR) and its associated co-regulators [<xref ref-type="bibr" rid="B158">158</xref>]. Similarly, under metabolic stress conditions, increased cellular SUMOylation (mainly by SUMO-2/3) can protect the brain during ischaemia or hibernation torpor [<xref ref-type="bibr" rid="B158">158</xref>–<xref ref-type="bibr" rid="B160">160</xref>]. Both in animal models and human patients, a fine balance between SUMO conjugation/deconjugation is critical for cardiac stress adaptation [<xref ref-type="bibr" rid="B155">155</xref>,<xref ref-type="bibr" rid="B156">156</xref>,<xref ref-type="bibr" rid="B161">161</xref>,<xref ref-type="bibr" rid="B162">162</xref>].</p>
<p>SUMOylation is not only essential for cardiac development, predominantly by regulating transcription factors, but also implicated in the onset of cardiac diseases [<xref ref-type="bibr" rid="B163">163</xref>–<xref ref-type="bibr" rid="B165">165</xref>]. Several K<sup>+</sup> channels found in the heart can be modulated by SUMO, such as K<sub>V</sub>2.1 [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>], a channel that helps set the cell resting potential [<xref ref-type="bibr" rid="B166">166</xref>]; K<sub>V</sub>1.5 [<xref ref-type="bibr" rid="B10">10</xref>], which controls excitability of atrial cells [<xref ref-type="bibr" rid="B167">167</xref>]; and K2P1 [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B6">6</xref>–<xref ref-type="bibr" rid="B9">9</xref>], which helps set resting membrane potential. SUMOylation also regulates the cardiac non-selective cationic channel TRPM4, which is localized predominantly in human atrial myocardium, and can act as a Ca<sup>2+</sup> regulator [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B168">168</xref>]. Progressive familial heart block type I, an autosomal dominant disease, has been linked to a mutation in the TRPM4 amino-terminal region that leads to increased TRPM4 SUMOylation and prevention of its ubiquitination and consequent proteasomal degradation [<xref ref-type="bibr" rid="B15">15</xref>]. Other proteins crucial for the maintenance of cardiomyocyte physiology, such as lamin A that plays a structural and functional role in the nucleus, are also reported to be SUMOylated [<xref ref-type="bibr" rid="B169">169</xref>,<xref ref-type="bibr" rid="B170">170</xref>]. Familial cardiomyopathy has been linked with mutations in the human laminin A gene, which were in turn associated with decreases in laminin A SUMOylation and accelerated cell death [<xref ref-type="bibr" rid="B169">169</xref>].</p>
<p>Disrupting Ca<sup>2+</sup> dynamics by interfering with other proteins or transcriptional factors that maintain Ca<sup>2+</sup> homoeostasis, such as some of TRP protein Ca<sup>2+</sup> entry channels or N-terminal serine residues of the nuclear factor of activated T cells (NFAT), can contribute to the onset of cardiac dysfunctions [<xref ref-type="bibr" rid="B171">171</xref>]. Increased intracellular Ca<sup>2+</sup> levels activate calcineurin, a Ca<sup>2+</sup>-calmodulin dependent serine–threonine protein phosphatase that dephosphorylates NFATs, leading to nuclear translocation of NFATs and activation of pro-hypertrophic genes [<xref ref-type="bibr" rid="B172">172</xref>]. SUMO-2 can activate calcineurin-NFAT signalling in cardiomyocytes leading to a hyperthophic phenotype, both <italic>in vitro</italic> and <italic>in vivo</italic> [<xref ref-type="bibr" rid="B173">173</xref>]. Unexpectedly, a conjugation-deficient SUMO-2 mutant (SUMO-2ΔGG) was equally capable to activate the pathway and promote hypertrophic effects, suggesting a SUMOylation-independent mechanism.</p>
<p>Proteins such as sarcoendoplasmic reticulum calcium ATPase (SERCA) in the sarcoplasmic reticulum and NCX in the cardiomyocyte membrane help to restore Ca<sup>2+</sup> concentrations at baseline following contraction [<xref ref-type="bibr" rid="B174">174</xref>]. The reduced expression or activity of SERCA2a is a hallmark of heart failure [<xref ref-type="bibr" rid="B175">175</xref>]. A proteomic screen has identified SERCA2a as a target for SUMO-1 (but not SUMO-2/3) at lysines 480 and 585 [<xref ref-type="bibr" rid="B156">156</xref>]. SUMO-1 and SERCA2a protein levels were decreased in animal models of heart failure, as well as in human cardiomyocytes isolated from failing ventricles. SUMO-1 overexpression restored SERCA2a levels, whereas either SUMO-1 or SERCA2a overexpression improved Ca<sup>2+</sup> handling, improving cardiac function. However, increased global SUMOylation in SERCA2a knockdown cardiomyocytes did not prevent contractile dysfunction, further confirming that SUMOylated SERCA2a is essential for cardiac function [<xref ref-type="bibr" rid="B156">156</xref>]. The small molecule N106 (<italic>N</italic>-(4-methoxybenzo[d]thiazol-2-yl)-5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-amine) was identified using an α-screen assay that detects SUMO-1 conjugation to nuclear RanGAP1 (the first and one of the most stable SUMO targets identified so far [<xref ref-type="bibr" rid="B176">176</xref>]). N106 promoted SERCA2a SUMOylation, resulting in enhanced contractility both in cultured cardiomyocytes and <italic>in vivo</italic>, significantly improving ventricular function in mice with heart failure [<xref ref-type="bibr" rid="B177">177</xref>]. N106 was proposed to directly activate the SUMO-activating enzyme [<xref ref-type="bibr" rid="B177">177</xref>].</p>
</sec>
<sec id="sec8">
<title>Concluding remarks</title>
<p>Both alterations in Ca<sup>2+</sup> homoeostasis and protein SUMOylation may lead to severe neurological, and also, cardiac pathologies. For example, SUMOylation of proteins involved in Ca<sup>2+</sup> signalling can modulate synapse formation and alter neurotransmitter release. Furthermore, SUMOylation of proteins can modulate Ca<sup>2+</sup> reuptake in cardiomyocytes and thus affect contractility. As described above and summarized in <xref ref-type="table" rid="T1">Table 1</xref>, it is clear that a wide range of proteins involved in these key physiological processes are subject to, potentially temporal, post-translational modification by different SUMO isoforms. Thus, at the presynapse, proteins involved in Ca<sup>2+</sup> homoeostasis, including VGCCs and their proteome, are emerging as SUMO targets; equally, synaptic proteins involved in exocytosis and endocytosis are known to be SUMOylated. Postsynaptic receptor SUMOylation can also impact synaptic function. There is clear potential to exploit this knowledge to improve synaptic function in neurodegenerative and hyperexcitability disorders and to improve cardiac function. Thus, understanding how SUMOylation affects Ca<sup>2+</sup> signalling in physiological and pathophysiological conditions is key to novel therapeutic strategies to prevent and/or cure important human diseases.</p>
<table-wrap id="T1" orientation="portrait" position="float">
<label>Table 1</label>
<caption>
<title>Potential functional consequences of SUMOylation in Ca<sup>2+</sup> signalling</title>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Target (direct or indirect)</th>
<th align="left" colspan="1" rowspan="1">SUMO isoform</th>
<th align="left" colspan="1" rowspan="1">Modified lysine</th>
<th align="left" colspan="1" rowspan="1">Mechanism or Ca<sup>2+</sup> channel type</th>
<th align="left" colspan="1" rowspan="1">Proposed SUMOylation effect</th>
<th align="left" colspan="1" rowspan="1">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">Ca<sub>V</sub>2.1 subunit (indirect)</td>
<td colspan="1" rowspan="1">SUMO-1</td>
<td colspan="1" rowspan="1">Unknown</td>
<td colspan="1" rowspan="1">Inhibition of P/Q-type Ca<sup>2+</sup> channels</td>
<td colspan="1" rowspan="1">Role in SCA6 pathogenesis</td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B124">124</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">CAMKII (indirect)</td>
<td colspan="1" rowspan="1">SUMO-1</td>
<td colspan="1" rowspan="1">Unknown</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">Differentiation of <italic>Drosophila</italic>’s nervous system</td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B141">141</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">CRMP2 (direct)</td>
<td colspan="1" rowspan="1">SUMO-1 SUMO-2/3</td>
<td colspan="1" rowspan="1">K374</td>
<td colspan="1" rowspan="1">Inhibition of N-type Ca<sup>2+</sup> channels</td>
<td colspan="1" rowspan="1">Reduces Ca<sup>2+</sup> influx in sensory neurons</td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B128">128</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">MEF2 (direct)</td>
<td colspan="1" rowspan="1">SUMO-1</td>
<td colspan="1" rowspan="1">K403</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">Promotes dendritic claw differentiation</td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B145">145</xref>,<xref ref-type="bibr" rid="B147">147</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">NCX3 (direct)</td>
<td colspan="1" rowspan="1">SUMO-1</td>
<td colspan="1" rowspan="1">K590</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">Inhibits NCX3 degradation</td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B85">85</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">NFAT (indirect)</td>
<td colspan="1" rowspan="1">SUMO-2</td>
<td colspan="1" rowspan="1">Unknown</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">Activates pro-hypertrophic genes</td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B173">173</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">RIM1α (direct)</td>
<td colspan="1" rowspan="1">SUMO-1</td>
<td colspan="1" rowspan="1">K502</td>
<td colspan="1" rowspan="1">Increase in P/Q-type Ca<sup>2+</sup> channel activity</td>
<td colspan="1" rowspan="1">Promotes synaptic vesicles release</td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B133">133</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">SERCA2a (direct)</td>
<td colspan="1" rowspan="1">SUMO-1</td>
<td colspan="1" rowspan="1">K480 and K585</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">Increases Ca<sup>2+</sup>reuptake to sarcoendoplasmic reticulum</td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B156">156</xref>,<xref ref-type="bibr" rid="B177">177</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Synapsin Ia (direct)</td>
<td colspan="1" rowspan="1">SUMO-1</td>
<td colspan="1" rowspan="1">K687</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">Sets up releasable synaptic vesicles</td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B138">138</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Synaptotagmin-1 (indirect)</td>
<td colspan="1" rowspan="1">SUMO-1</td>
<td colspan="1" rowspan="1">Unknown</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">Impairs neurotransmitter release</td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B139">139</xref>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Syntaxin 1A (direct)</td>
<td colspan="1" rowspan="1">SUMO-1</td>
<td colspan="1" rowspan="1">K252, K253 or K256</td>
<td colspan="1" rowspan="1">–</td>
<td colspan="1" rowspan="1">Increases vesicular endocytosis</td>
<td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B137">137</xref>]</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="T1TFN1">
<p>Abbreviations: CAMKII, Ca<sup>2+</sup>/calmodulin-dependent protein kinase II; CRMP2, collapsin response mediator protein 2; MEF2, myocyte enhancer factor 2; NCX3, isoform 3 of the Na<sup>+</sup>/Ca<sup>2+</sup> exchanger; NFAT, N-terminal serine residues of the nuclear factor of activated T-cells; RIM1α, Rab3a-interacting molecule 1α; SERCA2a, isoform 2a of sarcoendoplasmic reticulum Ca<sup>2+</sup> ATPase.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</body>
<back>
<ack id="ack1">
<title>Acknowledgements</title>
<p>Royal Society Newton Advanced and CNPq Fellowships together with IBRO and ISN/CAEN Return Home Awards to H.C. supported this work. L.C.S. is recipient of a CAPES MSc Studentship.</p>
</ack>
<sec id="sec9" sec-type="COI-statement">
<title>Competing Interests</title>
<p>The authors declare that there are no competing interests associated with the manuscript.</p>
</sec>
<glossary>
<title>Abbreviations</title>
<def-list list-content="abbreviations">
<def-item>
<term id="G1">Aβ</term>
<def>
<p>amyloid β</p>
</def>
</def-item>
<def-item>
<term id="G2">AD</term>
<def>
<p>Alzheimer's disease</p>
</def>
</def-item>
<def-item>
<term id="G3">APP</term>
<def>
<p>amyloid precursor protein</p>
</def>
</def-item>
<def-item>
<term id="G4">CNS</term>
<def>
<p>central nervous system</p>
</def>
</def-item>
<def-item>
<term id="G5">CRMP2</term>
<def>
<p>collapsin response mediator protein 2</p>
</def>
</def-item>
<def-item>
<term id="G6">Desi</term>
<def>
<p>deSUMOylating isopeptidase</p>
</def>
</def-item>
<def-item>
<term id="G7">DJ-1</term>
<def>
<p>PD (autosomal recessive, early onset) 7</p>
</def>
</def-item>
<def-item>
<term id="G8">DmSUMO-1</term>
<def>
<p><italic>Drosophila</italic> SUMO-1</p>
</def>
</def-item>
<def-item>
<term id="G9">Drp1</term>
<def>
<p>dynamin-related protein 1</p>
</def>
</def-item>
<def-item>
<term id="G10">MEF2A</term>
<def>
<p>myocyte enhancer factor 2A</p>
</def>
</def-item>
<def-item>
<term id="G11">NCX</term>
<def>
<p>sodium/calcium exchanger</p>
</def>
</def-item>
<def-item>
<term id="G12">NFAT</term>
<def>
<p>N-terminal serine residues of the nuclear factor of activated T cells</p>
</def>
</def-item>
<def-item>
<term id="G13">PD</term>
<def>
<p>Parkinson’s disease</p>
</def>
</def-item>
<def-item>
<term id="G14">PPAR</term>
<def>
<p>peroxisome proliferator-activated receptor</p>
</def>
</def-item>
<def-item>
<term id="G15">PPF</term>
<def>
<p>paired pulse facilitation</p>
</def>
</def-item>
<def-item>
<term id="G16">RIM</term>
<def>
<p>Rab3a-interacting molecule</p>
</def>
</def-item>
<def-item>
<term id="G17">SCA</term>
<def>
<p>spinocerebellar ataxia</p>
</def>
</def-item>
<def-item>
<term id="G18">SERCA</term>
<def>
<p>sarcoendoplasmic reticulum calcium ATPase</p>
</def>
</def-item>
<def-item>
<term id="G19">SIM</term>
<def>
<p>SUMO interacting motif</p>
</def>
</def-item>
<def-item>
<term id="G20">SNARE</term>
<def>
<p>soluble <italic>N</italic>-ethylmaleimide sensitive factor attachment protein receptors</p>
</def>
</def-item>
<def-item>
<term id="G21">SUMO</term>
<def>
<p>small ubiquitin-like modifier</p>
</def>
</def-item>
<def-item>
<term id="G22">TRP</term>
<def>
<p>transient receptor potential</p>
</def>
</def-item>
<def-item>
<term id="G23">TRPM4</term>
<def>
<p>transient receptor potential cation channel subfamily M member 4</p>
</def>
</def-item>
<def-item>
<term id="G24">Ubc9</term>
<def>
<p>ubiquitin-like conjugating enzyme 9</p>
</def>
</def-item>
<def-item>
<term id="G25">USPL1</term>
<def>
<p>ubiquitin-specific peptidase-like protein 1</p>
</def>
</def-item>
<def-item>
<term id="G26">VGCC</term>
<def>
<p>voltage-gated calcium channel</p>
</def>
</def-item>
</def-list>
</glossary>
<ref-list id="ref1">
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hay</surname><given-names>R.T.</given-names></name></person-group> (<year>2005</year>) <article-title>SUMO: a history of modification</article-title>. <source/>Mol. Cell.
<volume>18</volume>, <fpage>1</fpage>–<lpage>12</lpage><pub-id pub-id-type="pmid">15808504</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nacerddine</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Lehembre</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Bhaumik</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Artus</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Cohen-Tannoudji</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Babinet</surname><given-names>C.</given-names></name><etal>et al</etal>.</person-group> (<year>2005</year>) <article-title>The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice</article-title>. <source/>Dev. Cell
<volume>9</volume>, <fpage>769</fpage>–<lpage>779</lpage><pub-id pub-id-type="pmid">16326389</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plant</surname><given-names>L.D.</given-names></name>, <name name-style="western"><surname>Dementieva</surname><given-names>I.S.</given-names></name>, <name name-style="western"><surname>Kollewe</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Olikara</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Marks</surname><given-names>J.D.</given-names></name> and <name name-style="western"><surname>Goldstein</surname><given-names>S.A.</given-names></name></person-group> (<year>2010</year>) <article-title>One SUMO is sufficient to silence the dimeric potassium channel K2P1</article-title>. <source/>Proc. Natl Acad. Sci. U.S.A.
<volume>107</volume>, <fpage>10743</fpage>–<lpage>10748</lpage><pub-id pub-id-type="pmid">20498050</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silveirinha</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Stephens</surname><given-names>G.J.</given-names></name> and <name name-style="western"><surname>Cimarosti</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>) <article-title>Molecular targets underlying SUMO-mediated neuroprotection in brain ischemia</article-title>. <source/>J. Neurochem.
<volume>127</volume>, <fpage>580</fpage>–<lpage>591</lpage><pub-id pub-id-type="pmid">23786482</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doyle</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Morais-Cabral</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Pfuetzner</surname><given-names>R.A.</given-names></name>, <name name-style="western"><surname>Kuo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Gulbis</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>S.L.</given-names></name><etal>et al</etal>.</person-group> (<year>1998</year>) <article-title>The structure of the potassium channel: molecular basis of k1 conduction and selectivity</article-title>. <source/>Science
<volume>280</volume>, <fpage>69</fpage>–<lpage>77</lpage><pub-id pub-id-type="pmid">9525859</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajan</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Plant</surname><given-names>L.D.</given-names></name>, <name name-style="western"><surname>Rabin</surname><given-names>M.L.</given-names></name>, <name name-style="western"><surname>Butler</surname><given-names>M. H.</given-names></name> and <name name-style="western"><surname>Goldstein</surname><given-names>S.A.</given-names></name></person-group> (<year>2005</year>) <article-title>Sumoylation silences the plasma membrane leak K<sup>+</sup> channel K2P1</article-title>. <source/>Cell
<volume>121</volume>, <fpage>37</fpage>–<lpage>47</lpage><pub-id pub-id-type="pmid">15820677</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feliciangeli</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bendahhou</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sandoz</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Gounon</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Reichold</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Warth</surname><given-names>R.</given-names></name><etal>et al</etal>.</person-group> (<year>2007</year>) <article-title>Does sumoylation control K2P1/TWIK1 background K+ channels?</article-title>
<source/>Cell
<volume>130</volume>, <fpage>563</fpage>–<lpage>569</lpage><pub-id pub-id-type="pmid">17693262</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Es-Salah-Lamoureux</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Steele</surname><given-names>D.F.</given-names></name> and <name name-style="western"><surname>Fedida</surname><given-names>D.</given-names></name></person-group> (<year>2010</year>) <article-title>Research into the therapeutic roles of two-pore-domain potassium channels</article-title>. <source/>Trends Pharmacol. Sci.
<volume>31</volume>, <fpage>587</fpage>–<lpage>595</lpage><pub-id pub-id-type="pmid">20951446</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plant</surname><given-names>L.D.</given-names></name>, <name name-style="western"><surname>Zuniga</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Araki</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Marks</surname><given-names>J.D.</given-names></name> and <name name-style="western"><surname>Goldstein</surname><given-names>S.A.</given-names></name></person-group> (<year>2012</year>) <article-title>SUMOylation silences heterodimeric TASK potassium channels containing K2P1 subunits in cerebellar granule neurons</article-title>. <source/>Sci. Signal.
<volume>5</volume>, <fpage>ra84</fpage><pub-id pub-id-type="pmid">23169818</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benson</surname><given-names>M.D.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Q.J.</given-names></name>, <name name-style="western"><surname>Kieckhafer</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Dudek</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Whorton</surname><given-names>M.R.</given-names></name>, <name name-style="western"><surname>Sunahara</surname><given-names>R.K.</given-names></name><etal>et al</etal>.</person-group> (<year>2007</year>) <article-title>SUMO modification regulates inactivation of the voltage-gated potassium channel K<sub>V</sub>1.5</article-title>. <source/>Proc. Natl Acad. Sci. U.S.A.
<volume>104</volume>, <fpage>1805</fpage>–<lpage>1810</lpage><pub-id pub-id-type="pmid">17261810</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dai</surname><given-names>X.Q.</given-names></name>, <name name-style="western"><surname>Kolic</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Marchi</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Sipione</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Macdonald</surname><given-names>P.E.</given-names></name></person-group> (<year>2009</year>) <article-title>SUMOylation regulates K<sub>V</sub>2.1 and modulates pancreatic beta-cell excitability</article-title>. <source/>J. Cell Sci.
<volume>122</volume>, <fpage>775</fpage>–<lpage>779</lpage><pub-id pub-id-type="pmid">19223394</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plant</surname><given-names>L.D.</given-names></name>, <name name-style="western"><surname>Dowdell</surname><given-names>E.J.</given-names></name>, <name name-style="western"><surname>Dementieva</surname><given-names>I.S.</given-names></name>, <name name-style="western"><surname>Marks</surname><given-names>J.D.</given-names></name> and <name name-style="western"><surname>Goldstein</surname><given-names>S.A.</given-names></name></person-group> (<year>2011</year>) <article-title>SUMO modification of cell surface K<sub>V</sub>2.1 potassium channels regulates the activity of rat hippocampal neurons</article-title>. <source/>J. Gen. Physiol.
<volume>137</volume>, <fpage>441</fpage>–<lpage>454</lpage><pub-id pub-id-type="pmid">21518833</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bomben</surname><given-names>V.C.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>D.P.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>S.-R.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>H.</given-names></name><etal>et al</etal>.</person-group> (<year>2014</year>) <article-title>Hyper-SUMOylation of the K<sub>V</sub>7 potassium channel diminishes the M-current leading to seizures and sudden death</article-title>. <source/>Neuron
<volume>83</volume>, <fpage>1159</fpage>–<lpage>1171</lpage><pub-id pub-id-type="pmid">25189211</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dai</surname><given-names>X.Q.</given-names></name>, <name name-style="western"><surname>Spigelman</surname><given-names>A.F.</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Braun</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Manning-Fox</surname><given-names>J.E.</given-names></name> and <name name-style="western"><surname>Macdonald</surname><given-names>P.E.</given-names></name></person-group> (<year>2014</year>) <article-title>SUMO1 enhances cAMP-dependent exocytosis and glucagon secretion from pancreatic α-cells</article-title>. <source/>J. Physiol.
<volume>592</volume>, <fpage>3715</fpage>–<lpage>3726</lpage><pub-id pub-id-type="pmid">24907310</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kruse</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Schulze-Bahr</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Corfield</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Beckmann</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Stallmeyer</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Kurtbay</surname><given-names>G.</given-names></name><etal>et al</etal>.</person-group> (<year>2009</year>) <article-title>Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I</article-title>. <source/>J. Clin. Invest.
<volume>119</volume>, <fpage>2737</fpage>–<lpage>274</lpage><pub-id pub-id-type="pmid">19726882</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walsh</surname><given-names>C.T.</given-names></name>, <name name-style="western"><surname>Garneau-Tsodikova</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Gatto</surname><given-names>G.J.</given-names><suffix>Jr</suffix></name></person-group> (<year>2005</year>) <article-title>Protein posttranslational modifications: the chemistry of proteome diversifications</article-title>. <source/>Angew. Chem. Int. Ed. Engl.
<volume>45</volume>, <fpage>7342</fpage>–<lpage>7372</lpage></mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henley</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Craig</surname><given-names>T.J.</given-names></name> and <name name-style="western"><surname>Wilkinson</surname><given-names>K.A.</given-names></name></person-group> (<year>2014</year>) <article-title>Neuronal SUMOylation: mechanisms, physiology, and roles in neuronal dysfunction</article-title>. <source/>Physiol. Rev.
<volume>94</volume>, <fpage>1249</fpage>–<lpage>1258</lpage><pub-id pub-id-type="pmid">25287864</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hendriks</surname><given-names>I.A.</given-names></name>, <name name-style="western"><surname>D’Souza</surname><given-names>R.C.J.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Verlaan-de Vries</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mann</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Vertegaal</surname><given-names>A.C.O.</given-names></name></person-group> (<year>2014</year>) <article-title>Uncovering Global SUMOylation Signaling Networks in a Site-Specific Manner</article-title>. <source/>Nat. Struct. Mol. Biol.
<volume>10</volume>, <fpage>927</fpage>–<lpage>936</lpage></mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hendriks</surname><given-names>I.A.</given-names></name> and <name name-style="western"><surname>Vertegaal</surname><given-names>A.C.O.</given-names></name></person-group> (<year>2016</year>) <article-title>A comprehensive compilation of SUMO proteomics</article-title>. <source/>Nat. Rev. Mol. Cell Biol.
<volume>17</volume>, <fpage>581</fpage>–<lpage>595</lpage><pub-id pub-id-type="pmid">27435506</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>E.S.</given-names></name></person-group> (<year>2004</year>) <article-title>Protein modification by SUMO</article-title>. <source/>Annu. Rev. Biochem.
<volume>73</volume>, <fpage>355</fpage>–<lpage>382</lpage><pub-id pub-id-type="pmid">15189146</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Dasso</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>) <article-title>SUMOylation and deSUMOylation at a glance</article-title>. <source/>J. Cell Sci.
<volume>122</volume>, <fpage>4249</fpage>–<lpage>4252</lpage><pub-id pub-id-type="pmid">19923268</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sampson</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Matunis</surname><given-names>M.J.</given-names></name></person-group> (<year>2001</year>) <article-title>The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification</article-title>. <source/>J. Biol. Chem.
<volume>276</volume>, <fpage>21664</fpage>–<lpage>21669</lpage><pub-id pub-id-type="pmid">11259410</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sozen</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Horozoglu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bireller</surname><given-names>E.S.</given-names></name>, <name name-style="western"><surname>Karaali</surname><given-names>Z.</given-names></name> and <name name-style="western"><surname>Cakmakoglu</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>) <article-title>Association of SUMO4 M55V and -94ins/del gene variants with type-2 diabetes</article-title>. <source/>In Vivo
<volume>28</volume>, <fpage>919</fpage>–<lpage>923</lpage><pub-id pub-id-type="pmid">25189908</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sinha</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Yadav</surname><given-names>A.K.</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Dutta</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Bhansali</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Jha</surname><given-names>V.</given-names></name></person-group> (<year>2016</year>) <article-title>SUMO4 163 G&gt;A variation is associated with kidney disease in Indian subjects with type 2 diabetes</article-title>. <source/>Mol. Biol. Rep.
<volume>43</volume>, <fpage>345</fpage>–<lpage>348</lpage><pub-id pub-id-type="pmid">27055882</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>Y.C.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>C.C.</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>Y.L.</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>C.C.</given-names></name>, <name name-style="western"><surname>Schmitz</surname><given-names>M.L.</given-names></name> and <name name-style="western"><surname>Yang</surname><given-names>W.M.</given-names></name></person-group> (<year>2016</year>) <article-title>SUMO5, a novel poly-SUMO isoform, regulates PML nuclear bodies</article-title>. <source/>Sci. Rep.
<volume>6</volume>, <fpage>26509</fpage><pub-id pub-id-type="pmid">27211601</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodriguez</surname><given-names>M.S.</given-names></name>, <name name-style="western"><surname>Dargemont</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Hay</surname><given-names>R.T.</given-names></name></person-group> (<year>2001</year>) <article-title>SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting</article-title>. <source/>J. Biol. Chem.
<volume>276</volume>, <fpage>12654</fpage>–<lpage>12659</lpage><pub-id pub-id-type="pmid">11124955</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jardin</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Anselm</surname><given-names>H.C.</given-names></name> and <name name-style="western"><surname>Sticht</surname><given-names>H.</given-names></name></person-group> (<year>2015</year>) <article-title>Binding properties of SUMO-interacting motifs (SIMs) in yeast</article-title>. <source/>J. Mol. Model.
<volume>21</volume>, <fpage>50</fpage><pub-id pub-id-type="pmid">25690366</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flotho</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Melchior</surname><given-names>F.</given-names></name></person-group> (<year>2013</year>) <article-title>Sumoylation: a regulatory protein modification in health and disease</article-title>. <source/>Annu. Rev. Biochem.
<volume>82</volume>, <fpage>357</fpage>–<lpage>385</lpage><pub-id pub-id-type="pmid">23746258</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gareau</surname><given-names>J.R.</given-names></name> and <name name-style="western"><surname>Lima</surname><given-names>C.D.</given-names></name></person-group> (<year>2010</year>) <article-title>The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition</article-title>. <source/>Nat. Rev. Mol. Cell Biol.
<volume>11</volume>, <fpage>861</fpage>–<lpage>871</lpage><pub-id pub-id-type="pmid">21102611</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nayak</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Müller</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>) <article-title>SUMO-specific proteases/isopeptidases: SENPs and beyond</article-title>. <source/>Genome Biol.
<volume>15</volume>, <fpage>422</fpage><pub-id pub-id-type="pmid">25315341</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hickey</surname><given-names>C.M.</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>N.R.</given-names></name> and <name name-style="western"><surname>Hochstrasser</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>) <article-title>Function and regulation of SUMO proteases</article-title>. <source/>Nat. Rev. Mol. Cell Biol.
<volume>13</volume>, <fpage>755</fpage>–<lpage>766</lpage><pub-id pub-id-type="pmid">23175280</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Millas</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Maul</surname><given-names>G.G.</given-names></name> and <name name-style="western"><surname>Yeh</surname><given-names>E.T.</given-names></name></person-group> (<year>2000</year>) <article-title>Differential regulation of sentrinized proteins by a novel sentrin-specific protease</article-title>. <source/>J. Biol. Chem.
<volume>275</volume>, <fpage>3355</fpage>–<lpage>3359</lpage><pub-id pub-id-type="pmid">10652325</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Nishimune</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Mellor</surname><given-names>J.R.</given-names></name> and <name name-style="western"><surname>Henley</surname><given-names>J.M.</given-names></name></person-group> (<year>2007</year>) <article-title>SUMOylation regulates kainate-receptor-mediated synaptic transmission</article-title>. <source/>Nature
<volume>447</volume>, <fpage>321</fpage>–<lpage>325</lpage><pub-id pub-id-type="pmid">17486098</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loriol</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Parisot</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Poupon</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Gwizdek</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Martin</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>) <article-title>Developmental regulation andspatiotemporal redistribution of the sumoylation machinery in the rat central nervous system</article-title>. <source/>PLoS One
<volume>7</volume>, <fpage>e33757</fpage><pub-id pub-id-type="pmid">22438991</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loriol</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Khayachi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Poupon</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Gwizdek</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Martin</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>) <article-title>Activity-dependent regulation of the sumoylation machinery in rat hippocampal neurons</article-title>. <source/>Biol. Cell
<volume>105</volume>, <fpage>30</fpage>–<lpage>45</lpage><pub-id pub-id-type="pmid">23066795</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Z.</given-names></name> and <name name-style="western"><surname>Au</surname><given-names>S.W.</given-names></name></person-group> (<year>2005</year>) <article-title>Mapping residues of SUMO precursors essential in differential maturation by SUMO-specific protease, SENP1</article-title>. <source/>Biochem. J.
<volume>386</volume>, <fpage>325</fpage>–<lpage>330</lpage><pub-id pub-id-type="pmid">15487983</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>L.</given-names></name> and <name name-style="western"><surname>Yeh</surname><given-names>E.T.</given-names></name></person-group> (<year>2006</year>) <article-title>Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3</article-title>. <source/>J. Biol. Chem.
<volume>281</volume>, <fpage>15869</fpage>–<lpage>15877</lpage><pub-id pub-id-type="pmid">16608850</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolli</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Mikolajczyk</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Drag</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mukhopadhyay</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Moffatt</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Dasso</surname><given-names>M.</given-names></name><etal>et al</etal>.</person-group> (<year>2010</year>) <article-title>Distribution and paralogue specificity of mammalian deSUMOylating enzymes</article-title>. <source/>Biochem. J.
<volume>430</volume>, <fpage>335</fpage>–<lpage>344</lpage><pub-id pub-id-type="pmid">20590526</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hang</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Dasso</surname><given-names>M.</given-names></name></person-group> (<year>2002</year>) <article-title>Association of the human SUMO-1 protease SENP2 with the nuclear pore</article-title>. <source/>J. Biol. Chem.
<volume>277</volume>, <fpage>19961</fpage>–<lpage>19966</lpage><pub-id pub-id-type="pmid">11896061</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reverter</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Lima</surname><given-names>C.D.</given-names></name></person-group> (<year>2004</year>) <article-title>A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex</article-title>. <source/>Structure
<volume>12</volume>, <fpage>1519</fpage>–<lpage>1531</lpage><pub-id pub-id-type="pmid">15296745</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hildick</surname><given-names>K.L.</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Dearden</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Wilkinson</surname><given-names>K.A.</given-names></name> and <name name-style="western"><surname>Henley</surname><given-names>J.M.</given-names></name></person-group> (<year>2013</year>) <article-title>SENP3-mediated deSUMOylation of dynamin-related protein 1 promotes cell death following ischaemia</article-title>. <source/>EMBO J.
<volume>32</volume>, <fpage>1514</fpage>–<lpage>1528</lpage><pub-id pub-id-type="pmid">23524851</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zunino</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Schauss</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Rippstein</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Andrade-Navarro</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>McBride</surname><given-names>H.M.</given-names></name></person-group> (<year>2007</year>) <article-title>The SUMO protease SENP5 is required to maintain mitochondrial morphology and function</article-title>. <source/>J. Cell Sci.
<volume>120</volume>, <fpage>1178</fpage>–<lpage>1188</lpage><pub-id pub-id-type="pmid">17341580</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di-Bacco</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ouyang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>H.Y.</given-names></name>, <name name-style="western"><surname>Catic</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ploegh</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Gill</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>) <article-title>The SUMO-specific protease SENP5 is required for cell division</article-title>. <source/>Mol. Cell Biol.
<volume>26</volume>, <fpage>4489</fpage>–<lpage>4498</lpage><pub-id pub-id-type="pmid">16738315</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>L.N.</given-names></name>, <name name-style="western"><surname>Geoffroy</surname><given-names>M.C.</given-names></name>, <name name-style="western"><surname>Jaffray</surname><given-names>E.G.</given-names></name> and <name name-style="western"><surname>Hay</surname><given-names>R.T.</given-names></name></person-group> (<year>2009</year>) <article-title>Characterization of SENP7, a SUMO-2/3-specific isopeptidase</article-title>. <source/>Biochem. J.
<volume>421</volume>, <fpage>223</fpage>–<lpage>230</lpage><pub-id pub-id-type="pmid">19392659</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lima</surname><given-names>C.D.</given-names></name> and <name name-style="western"><surname>Reverter</surname><given-names>D.</given-names></name></person-group> (<year>2008</year>) <article-title>Structure of the human SENP7 catalytic domain and poly- SUMO deconjugation activities for SENP6 and SENP7</article-title>. <source/>J. Biol. Chem.
<volume>283</volume>, <fpage>32045</fpage>–<lpage>32055</lpage><pub-id pub-id-type="pmid">18799455</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>D.B.</given-names></name>, <name name-style="western"><surname>Zanella</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>Henley</surname><given-names>J.M.</given-names></name> and <name name-style="western"><surname>Cimarosti</surname><given-names>H.</given-names></name></person-group> (<year>2017</year>) <article-title>Sumoylation: implications for neurodegenerative diseases</article-title>. <source/>Adv. Exp. Med. Biol.
<volume>963</volume>, <fpage>261</fpage>–<lpage>281</lpage><pub-id pub-id-type="pmid">28197918</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dorval</surname><given-names>V.</given-names></name> and <name name-style="western"><surname>Fraser</surname><given-names>P.E.</given-names></name></person-group> (<year>2006</year>) <article-title>Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein</article-title>. <source/>J. Biol. Chem.
<volume>281</volume>, <fpage>9919</fpage>–<lpage>9924</lpage><pub-id pub-id-type="pmid">16464864</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.Q.</given-names></name> and <name name-style="western"><surname>Sarge</surname><given-names>K.D.</given-names></name></person-group> (<year>2008</year>) <article-title>Sumoylation of amyloid precursor protein negatively regulates Abeta aggregate levels</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>374</volume>, <fpage>673</fpage>–<lpage>678</lpage><pub-id pub-id-type="pmid">18675254</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geoffroy</surname><given-names>M.C.</given-names></name> and <name name-style="western"><surname>Hay</surname><given-names>R.T.</given-names></name></person-group> (<year>2009</year>) <article-title>An additional role for SUMO in ubiquitin-mediated proteolysis</article-title>. <source/>Nat. Rev. Mol. Cell Biol.
<volume>10</volume>, <fpage>564</fpage>–<lpage>568</lpage><pub-id pub-id-type="pmid">19474794</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haass</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Selkoe</surname><given-names>D.J.</given-names></name></person-group> (<year>2007</year>) <article-title>Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide</article-title>. <source/>Nat. Rev. Mol. Cell Biol.
<volume>8</volume>, <fpage>101</fpage>–<lpage>112</lpage><pub-id pub-id-type="pmid">17245412</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thornton</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Vink</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Blumbergs</surname><given-names>P.C.</given-names></name> and <name name-style="western"><surname>Heuvel</surname><given-names>C.V.D.</given-names></name></person-group> (<year>2006</year>) <article-title>Soluble amyloid precursor protein a reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats</article-title>. <source/>Brain Res.
<volume>1094</volume>, <fpage>38</fpage>–<lpage>46</lpage><pub-id pub-id-type="pmid">16697978</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Pedigo</surname><given-names>N.W.</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Hensley</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Butterfield</surname><given-names>D.A.</given-names></name> and <name name-style="western"><surname>Carney</surname><given-names>J.M.</given-names></name></person-group> (<year>1996</year>) <article-title>Amyloid β peptide (25–35) inhibits Na<sup>+</sup>-dependent glutamate uptake in rat hippocampal astrocyte cultures</article-title>. <source/>J. Neurochem.
<volume>67</volume>, <fpage>277</fpage>–<lpage>286</lpage><pub-id pub-id-type="pmid">8667003</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Quon</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.W.</given-names></name> and <name name-style="western"><surname>Cordell</surname><given-names>B.</given-names></name></person-group> (<year>2003</year>) <article-title>Positive and negative regulation of APP amyloidogenesis by sumoylation</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>100</volume>, <fpage>259</fpage>–<lpage>264</lpage><pub-id pub-id-type="pmid">12506199</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dorval</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Mazzella</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Mathews</surname><given-names>P.M.</given-names></name>, <name name-style="western"><surname>Hay</surname><given-names>R.T.</given-names></name> and <name name-style="western"><surname>Fraser</surname><given-names>P.E.</given-names></name></person-group> (<year>2007</year>) <article-title>Modulation of Abeta generation by small ubiquitin-like modifiers does not require conjugation to target proteins</article-title>. <source/>Biochem. J.
<volume>404</volume>, <fpage>309</fpage>–<lpage>316</lpage><pub-id pub-id-type="pmid">17346237</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yun</surname><given-names>S.M.</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>S.J.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>J.C.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>S.Y.</given-names></name>, <name name-style="western"><surname>Jo</surname><given-names>S.A.</given-names></name>, <name name-style="western"><surname>Jo</surname><given-names>C.</given-names></name><etal>et al</etal>.</person-group> (<year>2013</year>) <article-title>SUMO1 modulates Abeta generation via BACE1 accumulation</article-title>. <source/>Neurobiol. Aging
<volume>34</volume>, <fpage>650</fpage>–<lpage>662</lpage><pub-id pub-id-type="pmid">22975420</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weingarten</surname><given-names>M.D.</given-names></name>, <name name-style="western"><surname>Lockwood</surname><given-names>A.H.</given-names></name>, <name name-style="western"><surname>Hwo</surname><given-names>S.Y.</given-names></name> and <name name-style="western"><surname>Kirschner</surname><given-names>M.W.</given-names></name></person-group> (<year>1975</year>) <article-title>A protein factor essential for microtubule assembly</article-title>. <source/>Proc. Natl Acad. Sci. U.S.A.
<volume>72</volume>, <fpage>1858</fpage>–<lpage>1862</lpage><pub-id pub-id-type="pmid">1057175</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Selkoe</surname><given-names>D.</given-names></name></person-group> (<year>2001</year>) <article-title>Alzheimer’s disease: genes, proteins, and therapy</article-title>. <source/>Physiol. Rev.
<volume>81</volume>, <fpage>741</fpage>–<lpage>766</lpage><pub-id pub-id-type="pmid">11274343</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>S.J.</given-names></name>, <name name-style="western"><surname>Yun</surname><given-names>S.M.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>D.H.</given-names></name>, <name name-style="western"><surname>Jo</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Ho-Park</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>C.</given-names></name><etal>et al</etal>.</person-group> (<year>2015</year>) <article-title>Plasma SUMO-1 protein is elevated in Alzheimer's disease</article-title>. <source/>J. Alzheimers Dis.
<volume>47</volume>, <fpage>639</fpage>–<lpage>643</lpage><pub-id pub-id-type="pmid">26401699</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Dale</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Staniszewski</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Saeed</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Sakurai</surname><given-names>M.</given-names></name><etal>et al</etal>.</person-group> (<year>2014</year>) <article-title>Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease</article-title>. <source/>Sci. Rep.
<volume>4</volume>, <fpage>7190</fpage><pub-id pub-id-type="pmid">25448527</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McMillan</surname><given-names>L.E.</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>J.T.</given-names></name>, <name name-style="western"><surname>Henley</surname><given-names>J.M.</given-names></name> and <name name-style="western"><surname>Cimarosti</surname><given-names>H.</given-names></name></person-group> (<year>2011</year>) <article-title>Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model</article-title>. <source/>Neurosci. Lett.
<volume>502</volume>, <fpage>201</fpage>–<lpage>208</lpage><pub-id pub-id-type="pmid">21843595</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nistico</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Ferraina</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Marconi</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Blandini</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Negri</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Egebjerg</surname><given-names>J.</given-names></name><etal>et al</etal>.</person-group> (<year>2014</year>) <article-title>Age-related changes of protein SUMOylation balance in the AbetaPP Tg2576 mouse model of Alzheimer's disease</article-title>. <source/>Front. Pharmacol.
<volume>5</volume>, <fpage>63</fpage><pub-id pub-id-type="pmid">24778618</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Binda</surname><given-names>C.S.</given-names></name>, <name name-style="western"><surname>Heimann</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Duda</surname><given-names>J.K.</given-names></name>, <name name-style="western"><surname>Muller</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Henley</surname><given-names>J.M.</given-names></name> and <name name-style="western"><surname>Wilkinson</surname><given-names>K.A.</given-names></name></person-group> (<year>2017</year>) <article-title>Analysis of protein SUMOylation and SUMO pathway enzyme levels in Alzheimer’s disease and Down's syndrome</article-title>. <source/>Opera Med. Phys.
<volume>3</volume>, <fpage>19</fpage>–<lpage>24</lpage></mixed-citation>
</ref>
<ref id="B63">
<label>63.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eckermann</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>) <article-title>SUMO and Parkinson’s disease</article-title>. <source/>Neuromolecular Med.
<volume>15</volume>, <fpage>737</fpage>–<lpage>759</lpage><pub-id pub-id-type="pmid">23979994</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guerra de Souza</surname><given-names>A.C.</given-names></name>, <name name-style="western"><surname>Prediger</surname><given-names>R.D.</given-names></name> and <name name-style="western"><surname>Cimarosti</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>) <article-title>SUMO-regulated mitochondrial function in Parkinson’s disease</article-title>. <source/>J. Neurochem.
<volume>137</volume>, <fpage>673</fpage>–<lpage>686</lpage><pub-id pub-id-type="pmid">26932327</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maroteaux</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Campanelli</surname><given-names>J.T.</given-names></name> and <name name-style="western"><surname>Scheller</surname><given-names>R.H.</given-names></name></person-group> (<year>1988</year>) <article-title>Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal</article-title>. <source/>J. Neurosci.
<volume>8</volume>, <fpage>2804</fpage>–<lpage>2815</lpage><pub-id pub-id-type="pmid">3411354</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Golbe</surname><given-names>L.I.</given-names></name>, <name name-style="western"><surname>Iorio</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Di-Bonavita</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>D.C.</given-names></name> and <name name-style="western"><surname>Duvoisin</surname><given-names>R.C.</given-names></name></person-group> (<year>1990</year>) <article-title>A large kindred with autosomal dominant Parkinson’s disease</article-title>. <source/>Ann. Neurol.
<volume>27</volume>, <fpage>276</fpage>–<lpage>282</lpage><pub-id pub-id-type="pmid">2158268</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chandra</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Fornai</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Kwon</surname><given-names>H.B.</given-names></name>, <name name-style="western"><surname>Yazdani</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Atasoy</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><etal>et al</etal>.</person-group> (<year>2004</year>) <article-title>Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>101</volume>, <fpage>14966</fpage>–<lpage>14971</lpage><pub-id pub-id-type="pmid">15465911</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chandra</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Gallardo</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Fernandez-Chacon</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Schluter</surname><given-names>O.M.</given-names></name> and <name name-style="western"><surname>Sudhof</surname><given-names>T.C.</given-names></name></person-group> (<year>2005</year>) <article-title>Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration</article-title>. <source/>Cell
<volume>123</volume>, <fpage>383</fpage>–<lpage>396</lpage><pub-id pub-id-type="pmid">16269331</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>Y.M.</given-names></name>, <name name-style="western"><surname>Mouradian</surname><given-names>M.M.</given-names></name> and <name name-style="western"><surname>Chung</surname><given-names>K.C.</given-names></name></person-group> (<year>2011</year>) <article-title>Human polycomb protein 2 promotes alpha-synuclein aggregate formation through covalent SUMOylation</article-title>. <source/>Brain Res.
<volume>1381</volume>, <fpage>78</fpage>–<lpage>89</lpage><pub-id pub-id-type="pmid">21256122</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>M.J.L.</given-names></name>, <name name-style="western"><surname>Cook</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Mackay-Sim</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Poutney</surname><given-names>D.L.</given-names></name></person-group> (<year>2012</year>) <article-title>Differential SUMO-1 distribution in Parkinson’s disease patient neurosphere-derived cells in response to proteolytic stress (Abstract)</article-title>. <source/>Proteostasis and Disease Symposium</mixed-citation>
</ref>
<ref id="B71">
<label>71.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>M.B.</given-names></name>, <name name-style="western"><surname>Goodwin</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Norazit</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Meedeniya</surname><given-names>A.C.</given-names></name>, <name name-style="western"><surname>Richter-Landsberg</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Gai</surname><given-names>W.P.</given-names></name><etal>et al</etal>.</person-group> (<year>2013</year>) <article-title>SUMO-1 is associated with a subset of lysosomes in glial protein aggregate diseases</article-title>. <source/>Neurotox. Res.
<volume>23</volume>, <fpage>1</fpage>–<lpage>21</lpage><pub-id pub-id-type="pmid">23229893</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Um</surname><given-names>J.W.</given-names></name> and <name name-style="western"><surname>Chung</surname><given-names>K.C.</given-names></name></person-group> (<year>2006</year>) <article-title>Functional modulation of parkin through physical interaction with SUMO-1</article-title>. <source/>J. Neurosc. Res.
<volume>84</volume>, <fpage>1543</fpage>–<lpage>1554</lpage></mixed-citation>
</ref>
<ref id="B73">
<label>73.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonifati</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Rizzu</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>van-Baren</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Schaap</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Breedveld</surname><given-names>G.J.</given-names></name>, <name name-style="western"><surname>Krieger</surname><given-names>E.</given-names></name><etal>et al</etal>.</person-group> (<year>2003</year>) <article-title>Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism</article-title>. <source/>Science
<volume>299</volume>, <fpage>256</fpage>–<lpage>259</lpage><pub-id pub-id-type="pmid">12446870</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taira</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Niki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Iguchi-Ariga</surname><given-names>S.M.</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Ariga</surname><given-names>H.</given-names></name></person-group> (<year>2004</year>) <article-title>DJ-1 has a role in antioxidative stress to prevent cell death</article-title>. <source/>EMBO Rep.
<volume>5</volume>, <fpage>213</fpage>–<lpage>218</lpage><pub-id pub-id-type="pmid">14749723</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shinbo</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Niki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Taira</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ooe</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Takahashi-Niki</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Maita</surname><given-names>C.</given-names></name><etal>et al</etal>.</person-group> (<year>2006</year>) <article-title>Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities</article-title>. <source/>Cell Death Differ.
<volume>13</volume>, <fpage>96</fpage>–<lpage>108</lpage><pub-id pub-id-type="pmid">15976810</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Janer</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Werner</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Takahashi-Fujigasaki</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Daret</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Fujigasaki</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Takada</surname><given-names>K.</given-names></name><etal>et al</etal>.</person-group> (<year>2010</year>) <article-title>SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7</article-title>. <source/>Hum. Mol. Genet.
<volume>19</volume>, <fpage>181</fpage>–<lpage>195</lpage><pub-id pub-id-type="pmid">19843541</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>Y.J.</given-names></name>, <name name-style="western"><surname>Miyake</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Wakita</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>McMullen</surname><given-names>D.C.</given-names></name>, <name name-style="western"><surname>Azuma</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Auh</surname><given-names>S.</given-names></name><etal>et al</etal>.</person-group> (<year>2007</year>) <article-title>Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells</article-title>. <source/>J. Cereb. Blood Flow Metab.
<volume>27</volume>, <fpage>950</fpage>–<lpage>962</lpage><pub-id pub-id-type="pmid">16955077</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cimarosti</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lindberg</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bomholt</surname><given-names>S.F.</given-names></name>, <name name-style="western"><surname>Ronn</surname><given-names>L.C.</given-names></name> and <name name-style="western"><surname>Henley</surname><given-names>J.M.</given-names></name></person-group> (<year>2008</year>) <article-title>Increased protein SUMOylation following focal cerebral ischemia</article-title>. <source/>Neuropharmacology
<volume>54</volume>, <fpage>280</fpage>–<lpage>289</lpage><pub-id pub-id-type="pmid">17991493</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Sheng</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Homi</surname><given-names>H.M.</given-names></name>, <name name-style="western"><surname>Warner</surname><given-names>D.S.</given-names></name> and <name name-style="western"><surname>Paschen</surname><given-names>W.</given-names></name></person-group> (<year>2008</year>) <article-title>Cerebral ischemia/stroke and small ubiquitin-like modifier (SUMO) conjugation–a new target for therapeutic intervention?</article-title>
<source/>J. Neurochem.
<volume>106</volume>, <fpage>989</fpage>–<lpage>999</lpage><pub-id pub-id-type="pmid">18410505</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarge</surname><given-names>K.D.</given-names></name> and <name name-style="western"><surname>Park-Sarge</surname><given-names>O.K.</given-names></name></person-group> (<year>2011</year>) <article-title>SUMO and its role in human diseases</article-title>. <source/>Int. Rev. Cell Mol. Biol.
<volume>288</volume>, <fpage>167</fpage>–<lpage>183</lpage><pub-id pub-id-type="pmid">21482412</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cimarosti</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Ashikaga</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Jaafari</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Dearden</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Rubin</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Wilkinson</surname><given-names>K. A.</given-names></name><etal>et al</etal>.</person-group> (<year>2012</year>) <article-title>Enhanced SUMOylation and SENP-1 protein levels following oxygen and glucose deprivation in neurones</article-title>. <source/>J. Cereb. Blood Flow Metab.
<volume>32</volume>, <fpage>17</fpage>–<lpage>22</lpage><pub-id pub-id-type="pmid">21989481</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>T.J.</given-names></name>, <name name-style="western"><surname>Slupe</surname><given-names>A.M.</given-names></name> and <name name-style="western"><surname>Strack</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>) <article-title>Cell signaling and mitochondrial dynamics: Implications for neuronal function and neurodegenerative disease</article-title>. <source/>Neurobiol. Dis.
<volume>51</volume>, <fpage>13</fpage>–<lpage>26</lpage><pub-id pub-id-type="pmid">22297163</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>C.R.</given-names></name> and <name name-style="western"><surname>Blackstone</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>) <article-title>Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1</article-title>. <source/>Ann. NY Acad. Sci.
<volume>1201</volume>, <fpage>34</fpage>–<lpage>39</lpage><pub-id pub-id-type="pmid">20649536</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Molinaro</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Cuomo</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Pignataro</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Boscia</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Sirabella</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Pannaccione</surname><given-names>A.</given-names></name><etal>et al</etal>.</person-group> (<year>2008</year>) <article-title>Targeted disruption of Na+/Ca<sup>2+</sup> exchanger 3 (NCX3) gene leads to a worsening of ischemic brain damage</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>1179</fpage>–<lpage>1184</lpage><pub-id pub-id-type="pmid">18234895</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cuomo</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Pignataro</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Sirabella</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Molinaro</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Anzilotti</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Scorziello</surname><given-names>A.</given-names></name><etal>et al</etal>.</person-group> (<year>2016</year>) <article-title>SUMOylation of LYS590 of NCX3 f-Loop by SUMO-1 participates in brain neuroprotection induced by ischemic preconditioning</article-title>. <source/>Stroke
<volume>47</volume>, <fpage>1085</fpage>–<lpage>1093</lpage><pub-id pub-id-type="pmid">26979866</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dutting</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Schroder-Kress</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Sticht</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Enz</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>) <article-title>SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b</article-title>. <source/>Biochem. J.
<volume>435</volume>, <fpage>365</fpage>–<lpage>371</lpage><pub-id pub-id-type="pmid">21288202</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Konopacki</surname><given-names>F.A.</given-names></name>, <name name-style="western"><surname>Jaafari</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Rocca</surname><given-names>D.L.</given-names></name>, <name name-style="western"><surname>Wilkinson</surname><given-names>K.A.</given-names></name>, <name name-style="western"><surname>Chamberlain</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Rubin</surname><given-names>P.</given-names></name><etal>et al</etal>.</person-group> (<year>2011</year>) <article-title>Agonist-induced PKC phosphorylation regulates GluK2 SUMOylation and kainate receptor endocytosis</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>108</volume>, <fpage>19772</fpage>–<lpage>19777</lpage><pub-id pub-id-type="pmid">22089239</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caraci</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Battaglia</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Sortino</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Spampinato</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Molinaro</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Copani</surname><given-names>A.</given-names></name><etal>et al</etal>.</person-group> (<year>2012</year>) <article-title>Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic?</article-title>
<source/>Neurochem. Int.
<volume>61</volume>, <fpage>559</fpage>–<lpage>565</lpage><pub-id pub-id-type="pmid">22306345</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Q.J.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>C. P.</given-names></name> and <name name-style="western"><surname>Hou</surname><given-names>X.Y.</given-names></name></person-group> (<year>2012</year>) <article-title>SUMOylation of the kainate receptor subunit GluK2 contributes to the activation of the MLK3-JNK3 pathway following kainate stimulation</article-title>. <source/>FEBS Lett.
<volume>586</volume>, <fpage>1259</fpage>–<lpage>1264</lpage><pub-id pub-id-type="pmid">22483987</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schorova</surname><given-names>L.</given-names></name> and <name name-style="western"><surname>Martin</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>) <article-title>SUMOylation in synaptic function and dysfunction</article-title>. <source/>Front. Synaptic Neurosci.
<volume>8</volume>, <fpage>1</fpage>–<lpage>24</lpage><pub-id pub-id-type="pmid">26903854</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wheeler</surname><given-names>D.B.</given-names></name>, <name name-style="western"><surname>Randall</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Tsien</surname><given-names>R.W.</given-names></name></person-group> (<year>1994</year>) <article-title>Roles of N-type and Q-type Ca<sup>2+</sup> channels in supporting hippocampal synaptic transmission</article-title>. <source/>Science
<volume>264</volume>, <fpage>107</fpage>–<lpage>111</lpage><pub-id pub-id-type="pmid">7832825</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanabe</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Beam</surname><given-names>K.G.</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>B.A.</given-names></name>, <name name-style="western"><surname>Niidome</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Numa</surname><given-names>S.</given-names></name></person-group> (<year>1990</year>) <article-title>Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling</article-title>. <source/>Nature
<volume>346</volume>, <fpage>567</fpage>–<lpage>569</lpage><pub-id pub-id-type="pmid">2165570</pub-id></mixed-citation>
</ref>
<ref id="B93">
<label>93.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dolmetsch</surname><given-names>R.E.</given-names></name>, <name name-style="western"><surname>Pajvani</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Fife</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Spotts</surname><given-names>J.M.</given-names></name> and <name name-style="western"><surname>Greenberg</surname><given-names>M.E.</given-names></name></person-group> (<year>2001</year>) <article-title>Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway</article-title>. <source/>Science
<volume>294</volume>, <fpage>333</fpage>–<lpage>339</lpage><pub-id pub-id-type="pmid">11598293</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wheeler</surname><given-names>D.G.</given-names></name>, <name name-style="western"><surname>Groth</surname><given-names>R.D.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Barret</surname><given-names>C.F.</given-names></name>, <name name-style="western"><surname>Owen</surname><given-names>S.F.</given-names></name>, <name name-style="western"><surname>Safa</surname><given-names>P.</given-names></name><etal>et al</etal>.</person-group> (<year>2012</year>) <article-title>Ca<sub>V.l</sub>1 and Ca<sub>V</sub>2 channels engage distinct modes of Ca<sup>2+</sup> signaling to control CREB dependent gene expression</article-title>. <source/>Cell
<volume>149</volume>, <fpage>1112</fpage>–<lpage>1124</lpage><pub-id pub-id-type="pmid">22632974</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clapham</surname><given-names>D.E.</given-names></name></person-group> (<year>2007</year>) <article-title>Calcium signaling</article-title>. <source/>Cell
<volume>131</volume>, <fpage>1047</fpage>–<lpage>1058</lpage><pub-id pub-id-type="pmid">18083096</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zamponi</surname><given-names>G.W.</given-names></name></person-group> (<year>2016</year>) <article-title>Targeting voltage-gated calcium channels in neurological and psychiatric diseases</article-title>. <source/>Nat. Rev.
<volume>15</volume>, <fpage>19</fpage>–<lpage>34</lpage></mixed-citation>
</ref>
<ref id="B97">
<label>97.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hagiwara</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ozawa</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Sand</surname><given-names>O.</given-names></name></person-group> (<year>1975</year>) <article-title>Voltage clamp analysis of two inward current mechanisms in the egg cell membrane of a starfish</article-title>. <source/>J. Gen. Physiol.
<volume>65</volume>, <fpage>617</fpage>–<lpage>644</lpage><pub-id pub-id-type="pmid">240906</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bean</surname><given-names>B.P.</given-names></name></person-group> (<year>1989</year>) <article-title>Classes of calcium channels in vertebrate cells</article-title>. <source/>Annu. Rev. Physiol.
<volume>51</volume>, <fpage>367</fpage>–<lpage>384</lpage><pub-id pub-id-type="pmid">2540697</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nowycky</surname><given-names>M.C.</given-names></name>, <name name-style="western"><surname>Fox</surname><given-names>A.P.</given-names></name> and <name name-style="western"><surname>Tsien</surname><given-names>R.W.</given-names></name></person-group> (<year>1985</year>) <article-title>Three types of neuronal calcium channel with different calcium agonist sensitivity</article-title>. <source/>Nature
<volume>316</volume>, <fpage>440</fpage>–<lpage>443</lpage><pub-id pub-id-type="pmid">2410796</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zamponi</surname><given-names>G.W.</given-names></name>, <name name-style="western"><surname>Striessnig</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Koschak</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Dolphin</surname><given-names>A.C</given-names></name></person-group> (<year>2015</year>) <article-title>The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential</article-title>. <source/>Pharmacol. Rev.
<volume>67</volume>, <fpage>821</fpage>–<lpage>870</lpage><pub-id pub-id-type="pmid">26362469</pub-id></mixed-citation>
</ref>
<ref id="B101">
<label>101.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berridge</surname><given-names>M.J.</given-names></name></person-group> (<year>2014</year>) <article-title>Ion channels</article-title>. <source/>Cell Signal. Biol.
<fpage>1</fpage>–<lpage>74</lpage></mixed-citation>
</ref>
<ref id="B102">
<label>102.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Felix</surname><given-names>R.</given-names></name></person-group> (<year>2006</year>) <article-title>Calcium channelopathies</article-title>. <source/>Neuromolecular Med.
<volume>8</volume>, <fpage>307</fpage>–<lpage>318</lpage><pub-id pub-id-type="pmid">16775382</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lory</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Mezghrani</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>) <article-title>Calcium channelopathies in inherited neurological disorders: relevance to drug screening for acquired channel disorders</article-title>. <source/>IDrugs
<volume>13</volume>, <fpage>467</fpage>–<lpage>471</lpage><pub-id pub-id-type="pmid">20582871</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Bading</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Mauceri</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>) <article-title>Dysfunction of neuronal calcium signaling in aging and disease</article-title>. <source/>Cell Tissue Res.
<volume>2</volume>, <fpage>381</fpage>–<lpage>383</lpage></mixed-citation>
</ref>
<ref id="B105">
<label>105.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steinlein</surname><given-names>O.K.</given-names></name></person-group> (<year>2014</year>) <article-title>Calcium signaling and epilepsy</article-title>. <source/>Cell Tissue Res.
<volume>2</volume>, <fpage>385</fpage>–<lpage>393</lpage></mixed-citation>
</ref>
<ref id="B106">
<label>106.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schäfer</surname><given-names>M.K.E.</given-names></name>, <name name-style="western"><surname>Pfeiffer</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Jaeckel</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Pouya</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Dolga</surname><given-names>A.M.</given-names></name> and <name name-style="western"><surname>Methner</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>) <article-title>Regulators of mitochondrial Ca<sup>2+</sup> homeostasis in cerebral ischemia</article-title>. <source/>Cell Tissue Res.
<volume>357</volume>, <fpage>395</fpage>–<lpage>405</lpage><pub-id pub-id-type="pmid">24715113</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bourinet</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Altier</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hildebrand</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Trang</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Salter</surname><given-names>M.W.</given-names></name> and <name name-style="western"><surname>Zamponi</surname><given-names>G.W.</given-names></name></person-group> (<year>2014</year>) <article-title>Calcium-permeable ion channels in pain signaling</article-title>. <source/>Physiol. Rev.
<volume>94</volume>, <fpage>81</fpage>–<lpage>140</lpage><pub-id pub-id-type="pmid">24382884</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Waxman</surname><given-names>S.G.</given-names></name> and <name name-style="western"><surname>Zamponi</surname><given-names>G.W.</given-names></name></person-group> (<year>2014</year>) <article-title>Regulating excitability of peripheral afferents: emerging ion channel targets</article-title>. <source/>Nat. Neurosci.
<volume>17</volume>, <fpage>153</fpage>–<lpage>163</lpage><pub-id pub-id-type="pmid">24473263</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miljanich</surname><given-names>G.P.</given-names></name></person-group> (<year>2004</year>) <article-title>Ziconotide: neuronal calcium channel blocker for treating severe chronic pain</article-title>. <source/>Curr. Med. Chem.
<volume>11</volume>, <fpage>3029</fpage>–<lpage>3040</lpage><pub-id pub-id-type="pmid">15578997</pub-id></mixed-citation>
</ref>
<ref id="B110">
<label>110.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rauck</surname><given-names>R.L.</given-names></name>, <name name-style="western"><surname>Wallace</surname><given-names>M.S.</given-names></name>, <name name-style="western"><surname>Burton</surname><given-names>A.W.</given-names></name>, <name name-style="western"><surname>Kapural</surname><given-names>L.</given-names></name> and <name name-style="western"><surname>North</surname><given-names>J.M.</given-names></name></person-group> (<year>2009</year>) <article-title>Intrathecal ziconotide for neuropathic pain: a review</article-title>. <source/>Pain Pract.
<volume>9</volume>, <fpage>327</fpage>–<lpage>337</lpage><pub-id pub-id-type="pmid">19682321</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>H.S.</given-names></name> and <name name-style="western"><surname>Deer</surname><given-names>T.R.</given-names></name></person-group> (<year>2009</year>) <article-title>Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain</article-title>. <source/>Ther. Clin. Risk Manag.
<volume>5</volume>, <fpage>521</fpage>–<lpage>534</lpage><pub-id pub-id-type="pmid">19707262</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cizkova</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Marsala</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lukacova</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Marsala</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Jergova</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Orendacova</surname><given-names>J.</given-names></name><etal>et al</etal>.</person-group> (<year>2002</year>) <article-title>Localization of N-type Ca<sup>2+</sup> channels in the rat spinal cord following chronic constrictive nerve injury</article-title>. <source/>Exp. Brain Res.
<volume>147</volume>, <fpage>456</fpage>–<lpage>463</lpage><pub-id pub-id-type="pmid">12444477</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jagodic</surname><given-names>M.M.</given-names></name>, <name name-style="western"><surname>Pathirathna</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Joksovic</surname><given-names>P.M.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>M.T.</given-names></name>, <name name-style="western"><surname>Naik</surname><given-names>A.K.</given-names></name><etal>et al</etal>.</person-group> (<year>2008</year>) <article-title>Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve</article-title>. <source/>J. Neurophysiol.
<volume>99</volume>, <fpage>3151</fpage>–<lpage>3156</lpage><pub-id pub-id-type="pmid">18417624</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marger</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Gelot</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Alloui</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Matricon</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Ferrer</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>Barrère</surname><given-names>C.</given-names></name><etal>et al</etal>.</person-group> (<year>2011</year>) <article-title>T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>108</volume>, <fpage>11268</fpage>–<lpage>11273</lpage><pub-id pub-id-type="pmid">21690417</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bezprozvanny</surname><given-names>I.</given-names></name> and <name name-style="western"><surname>Mattson</surname><given-names>M.P.</given-names></name></person-group> (<year>2008</year>) <article-title>Neuronal calcium mishandling and the pathogenesis of Alzheimer’s disease</article-title>. <source/>Trends Neurosci.
<volume>31</volume>, <fpage>454</fpage>–<lpage>463</lpage><pub-id pub-id-type="pmid">18675468</pub-id></mixed-citation>
</ref>
<ref id="B116">
<label>116.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brawek</surname><given-names>B.</given-names></name> and <name name-style="western"><surname>Garaschuk</surname><given-names>O.</given-names></name></person-group> (<year>2014</year>) <article-title>Network-wide dysregulation of calcium homeostasis in Alzheimer’s disease</article-title>. <source/>Cell Tissue Res.
<volume>357</volume>, <fpage>427</fpage>–<lpage>438</lpage><pub-id pub-id-type="pmid">24553999</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mezler</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Barghorn</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Schoemaker</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Gross</surname><given-names>G.</given-names></name> and <name name-style="western"><surname>Nimmrich</surname><given-names>V.</given-names></name></person-group> (<year>2012</year>) <article-title>A β-amyloid oligomer directly modulates P/Q-type calcium currents in Xenopus oocytes</article-title>. <source/>Br. J. Pharmacol.
<volume>165</volume>, <fpage>1572</fpage>–<lpage>1583</lpage><pub-id pub-id-type="pmid">21883149</pub-id></mixed-citation>
</ref>
<ref id="B118">
<label>118.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hermann</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Mezler</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Müller</surname><given-names>M.K.</given-names></name>, <name name-style="western"><surname>Wicke</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Gross</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Draguhn</surname><given-names>A.</given-names></name><etal>et al</etal>.</person-group> (<year>2013</year>) <article-title>Synthetic Aβ oligomers (Aβ(1-42) globulomer) modulate presynaptic calcium currents: prevention of Aβ-induced synaptic deficits by calcium channel blockers</article-title>. <source/>Eur. J. Pharmacol.
<volume>702</volume>, <fpage>44</fpage>–<lpage>55</lpage><pub-id pub-id-type="pmid">23376566</pub-id></mixed-citation>
</ref>
<ref id="B119">
<label>119.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rush</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Buisson</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>) <article-title>Reciprocal disruption of neuronal signaling and Aβ production mediated by extrasynaptic NMDA receptors: a downward spiral</article-title>. <source/>Cell Tissue Res.
<volume>356</volume>, <fpage>279</fpage>–<lpage>286</lpage><pub-id pub-id-type="pmid">24496511</pub-id></mixed-citation>
</ref>
<ref id="B120">
<label>120.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Putzier</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Kullmann</surname><given-names>P.H.</given-names></name>, <name name-style="western"><surname>Horn</surname><given-names>J.P.</given-names></name> and <name name-style="western"><surname>Levitan</surname><given-names>E.S.</given-names></name></person-group> (<year>2009</year>) <article-title>Ca<sub>V</sub>1.3 channel voltage dependence, not Ca<sup>2+</sup> selectivity, drives pacemaker activity and amplifies bursts in nigral dopamine neurons</article-title>. <source/>J. Neurosci.
<volume>29</volume>, <fpage>15414</fpage>–<lpage>15419</lpage><pub-id pub-id-type="pmid">20007466</pub-id></mixed-citation>
</ref>
<ref id="B121">
<label>121.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Surmeier</surname><given-names>D.J.</given-names></name> and <name name-style="western"><surname>Schumacker</surname><given-names>P.T.</given-names></name></person-group> (<year>2013</year>) <article-title>Calcium, bioenergetics, and neuronal vulnerability in Parkinson’s disease</article-title>. <source/>J. Biol. Chem.
<volume>288</volume>, <fpage>10736</fpage>–<lpage>10741</lpage><pub-id pub-id-type="pmid">23086948</pub-id></mixed-citation>
</ref>
<ref id="B122">
<label>122.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rcom-H’cheo-Gauthier</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Goodwin</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Pountney</surname><given-names>D.L.</given-names></name></person-group> (<year>2014</year>) <article-title>Interactions between calcium and alpha-synuclein in neurodegeneration Biomolecules</article-title>
<volume>4</volume>, <fpage>795</fpage>–<lpage>811</lpage></mixed-citation>
</ref>
<ref id="B123">
<label>123.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhuchenko</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bonnen</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Ashizawa</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Stockton</surname><given-names>D.W.</given-names></name>, <name name-style="western"><surname>Amos</surname><given-names>C.</given-names></name><etal>et al</etal>.</person-group> (<year>1997</year>) <article-title>Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel</article-title>. <source/>Nat. Genet.
<volume>15</volume>, <fpage>62</fpage>–<lpage>69</lpage><pub-id pub-id-type="pmid">8988170</pub-id></mixed-citation>
</ref>
<ref id="B124">
<label>124.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davila</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Piedras-Renteria</surname><given-names>E.S.</given-names></name></person-group> (<year>2010</year>) <article-title>SUMOylation of voltage-gated alphaA1a calcium channels</article-title>. <source/>Biophys. J.
<volume>98</volume>, <fpage>692a</fpage>–<lpage>693a</lpage></mixed-citation>
</ref>
<ref id="B125">
<label>125.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feligioni</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Nishimune</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Henley</surname><given-names>J.M.</given-names></name></person-group> (<year>2009</year>) <article-title>Protein SUMOylation modulates calcium influx and glutamate release from presynaptic terminals</article-title>. <source/>Eur. J. Neurosci.
<volume>29</volume>, <fpage>1348</fpage>–<lpage>1356</lpage><pub-id pub-id-type="pmid">19344328</pub-id></mixed-citation>
</ref>
<ref id="B126">
<label>126.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Müller</surname><given-names>C.S.</given-names></name>, <name name-style="western"><surname>Haupt</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bildl</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Schindler</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Knaus</surname><given-names>H.G.</given-names></name>, <name name-style="western"><surname>Meissner</surname><given-names>M.</given-names></name><etal>et al</etal>.</person-group> (<year>2010</year>) <article-title>Quantitative proteomics of the Ca<sub>V</sub>2 channel nano-environments in the mammalian brain</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>107</volume>, <fpage>14950</fpage>–<lpage>14957</lpage><pub-id pub-id-type="pmid">20668236</pub-id></mixed-citation>
</ref>
<ref id="B127">
<label>127.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brittain</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Piekarz</surname><given-names>A.D.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kondo</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Cummins</surname><given-names>T.R.</given-names></name> and <name name-style="western"><surname>Khanna</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>) <article-title>An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels</article-title>. <source/>J. Biol. Chem.
<volume>284</volume>, <fpage>31375</fpage>–<lpage>31390</lpage><pub-id pub-id-type="pmid">19755421</pub-id></mixed-citation>
</ref>
<ref id="B128">
<label>128.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ju</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>S.M.</given-names></name>, <name name-style="western"><surname>Brittain</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Meroueh</surname><given-names>L.</given-names></name> and <name name-style="western"><surname>Khanna</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>) <article-title>SUMOylation alters CRMP2 regulation of calcium influx in sensory neurons</article-title>. <source/>Channels (Austin)
<volume>7</volume>, <fpage>153</fpage>–<lpage>159</lpage><pub-id pub-id-type="pmid">23510938</pub-id></mixed-citation>
</ref>
<ref id="B129">
<label>129.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dustrude</surname><given-names>E.T.</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>S.M.</given-names></name>, <name name-style="western"><surname>Ju</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Khanna</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>) <article-title>CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking</article-title>. <source/>J. Biol. Chem.
<volume>288</volume>, <fpage>24316</fpage>–<lpage>24331</lpage><pub-id pub-id-type="pmid">23836888</pub-id></mixed-citation>
</ref>
<ref id="B130">
<label>130.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dib-Hajj</surname><given-names>S. D.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Black</surname><given-names>J.A.</given-names></name> and <name name-style="western"><surname>Waxman</surname><given-names>S.G.</given-names></name></person-group> (<year>2013</year>) <article-title>The NaV1.7 sodium channel: from molecule to man</article-title>. <source/>Nat. Rev. Neurosci.
<volume>14</volume>, <fpage>49</fpage>–<lpage>62</lpage><pub-id pub-id-type="pmid">23232607</pub-id></mixed-citation>
</ref>
<ref id="B131">
<label>131.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deng</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Kaeser</surname><given-names>P.S.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name> and <name name-style="western"><surname>Sudhof</surname><given-names>T.C.</given-names></name></person-group> (<year>2011</year>) <article-title>RIM proteins activate vesicle priming by reversing autoinhibitory homodimerization of Munc13</article-title>. <source/>Neuron
<volume>69</volume>, <fpage>317</fpage>–<lpage>331</lpage><pub-id pub-id-type="pmid">21262469</pub-id></mixed-citation>
</ref>
<ref id="B132">
<label>132.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaeser</surname><given-names>P.S.</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Dulubova</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Rizo</surname><given-names>J.</given-names></name><etal>et al</etal>.</person-group> (<year>2011</year>) <article-title>RIM proteins tether Ca<sup>2+</sup> channels to presynaptic active zones via a direct PDZ-domain interaction</article-title>. <source/>Cell
<volume>144</volume>, <fpage>282</fpage>–<lpage>295</lpage><pub-id pub-id-type="pmid">21241895</pub-id></mixed-citation>
</ref>
<ref id="B133">
<label>133.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Girach</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Craig</surname><given-names>T.J.</given-names></name>, <name name-style="western"><surname>Rocca</surname><given-names>D.L.</given-names></name> and <name name-style="western"><surname>Henley</surname><given-names>J.M.</given-names></name></person-group> (<year>2013</year>) <article-title>RIM1a SUMOylation is required for fast synaptic vesicle exocytosis</article-title>. <source/>Cell Rep.
<volume>5</volume>, <fpage>1294</fpage>–<lpage>1301</lpage><pub-id pub-id-type="pmid">24290762</pub-id></mixed-citation>
</ref>
<ref id="B134">
<label>134.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Südhof</surname><given-names>T.C.</given-names></name></person-group> (<year>2013</year>) <article-title>Neurotransmitter release: the last millisecond in the life of a synaptic vesicle</article-title>. <source/>Neuron
<volume>80</volume>, <fpage>675</fpage>–<lpage>690</lpage><pub-id pub-id-type="pmid">24183019</pub-id></mixed-citation>
</ref>
<ref id="B135">
<label>135.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Xue</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>X.S.</given-names></name>, <name name-style="western"><surname>Chiang</surname><given-names>H.C.</given-names></name><etal>et al</etal>.</person-group> (<year>2013</year>) <article-title>SNARE proteins synaptobrevin, SNAP-25, and syntaxin are involved in rapid and slow endocytosis at synapses</article-title>. <source/>Cell Rep.
<volume>3</volume>, <fpage>1414</fpage>–<lpage>1421</lpage><pub-id pub-id-type="pmid">23643538</pub-id></mixed-citation>
</ref>
<ref id="B136">
<label>136.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Chiang</surname><given-names>H.C.</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>W.</given-names></name><etal>et al</etal>.</person-group> (<year>2013</year>) <article-title>The SNARE proteins SNAP25 and synaptobrevin are involved in endocytosis at hippocampal synapses</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>9169</fpage>–<lpage>9175</lpage><pub-id pub-id-type="pmid">23699527</pub-id></mixed-citation>
</ref>
<ref id="B137">
<label>137.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Craig</surname><given-names>T.J.</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>A.J.</given-names></name>, <name name-style="western"><surname>Girach</surname><given-names>F.</given-names></name> and <name name-style="western"><surname>Henley</surname><given-names>J.M.</given-names></name></person-group> (<year>2015</year>) <article-title>SUMOylation of syntaxin1A regulates presynaptic endocytosis</article-title>. <source/>Sci. Rep.
<volume>5</volume>, <fpage>17669</fpage><pub-id pub-id-type="pmid">26635000</pub-id></mixed-citation>
</ref>
<ref id="B138">
<label>138.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>L.T.</given-names></name>, <name name-style="western"><surname>Craig</surname><given-names>T.J.</given-names></name> and <name name-style="western"><surname>Henley</surname><given-names>J.M.</given-names></name></person-group> (<year>2015</year>) <article-title>SUMOylation of synapsin Ia maintains synaptic vesicle availability and is reduced in an autism mutation</article-title>. <source/>Nat. Commun.
<volume>6</volume>, <fpage>7728</fpage><pub-id pub-id-type="pmid">26173895</pub-id></mixed-citation>
</ref>
<ref id="B139">
<label>139.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsuzaki</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Knock</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Srikumar</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Sakurai</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hazrati</surname><given-names>L.N.</given-names></name><etal>et al</etal>.</person-group> (<year>2015</year>) <article-title>SUMO-1 affects synaptic function, spine density and memory</article-title>. <source/>Sci. Rep.
<volume>5</volume>, <fpage>10730</fpage><pub-id pub-id-type="pmid">26022678</pub-id></mixed-citation>
</ref>
<ref id="B140">
<label>140.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lisman</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Schulman</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Cline</surname><given-names>H.</given-names></name></person-group> (<year>2002</year>) <article-title>The molecular basis of CaMKII function in synaptic and behavioural memory</article-title>. <source/>Nat. Rev. Neurosci.
<volume>3</volume>, <fpage>175</fpage>–<lpage>190</lpage><pub-id pub-id-type="pmid">11994750</pub-id></mixed-citation>
</ref>
<ref id="B141">
<label>141.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Long</surname><given-names>X.</given-names></name> and <name name-style="western"><surname>Griffith</surname><given-names>L.C.</given-names></name></person-group> (<year>2000</year>) <article-title>Identification and characterization of a SUMO-1 conjugation system that modifies neuronal calcium/calmodulin-dependent protein kinase II in <italic>Drosophila melanogaster</italic></article-title>. <source/>J. Biol. Chem.
<volume>275</volume>, <fpage>40765</fpage>–<lpage>40776</lpage><pub-id pub-id-type="pmid">10995744</pub-id></mixed-citation>
</ref>
<ref id="B142">
<label>142.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flavell</surname><given-names>S.W.</given-names></name>, <name name-style="western"><surname>Cowan</surname><given-names>C.W.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>T.K.</given-names></name>, <name name-style="western"><surname>Greer</surname><given-names>P.L.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Paradis</surname><given-names>S.</given-names></name><etal>et al</etal>.</person-group> (<year>2006</year>) <article-title>Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number</article-title>. <source/>Science
<volume>311</volume>, <fpage>1008</fpage>–<lpage>1012</lpage><pub-id pub-id-type="pmid">16484497</pub-id></mixed-citation>
</ref>
<ref id="B143">
<label>143.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hietakangas</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Anckar</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Blomster</surname><given-names>H.A.</given-names></name>, <name name-style="western"><surname>Fujimoto</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Palvimo</surname><given-names>J.J.</given-names></name>, <name name-style="western"><surname>Nakai</surname><given-names>A.</given-names></name><etal>et al</etal>.</person-group> (<year>2006</year>) <article-title>PDSM, a motif for phosphorylation-dependent SUMO modification</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>103</volume>, <fpage>45</fpage>–<lpage>50</lpage><pub-id pub-id-type="pmid">16371476</pub-id></mixed-citation>
</ref>
<ref id="B144">
<label>144.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Gocke</surname><given-names>C.B.</given-names></name> and <name name-style="western"><surname>Yu</surname><given-names>H.</given-names></name></person-group> (<year>2006</year>) <article-title>Phosphorylation-facilitated SUMOylation of MEF2C negatively regulates its transcriptional activity</article-title>. <source/>BMC Biochem.
<volume>7</volume>, <fpage>5</fpage><pub-id pub-id-type="pmid">16478538</pub-id></mixed-citation>
</ref>
<ref id="B145">
<label>145.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riquelme</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Barthel</surname><given-names>K.K.</given-names></name> and <name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name></person-group> (<year>2006</year>) <article-title>SUMO-1 modification of MEF2A regulates its transcriptional activity</article-title>. <source/>J. Cell. Mol. Med.
<volume>10</volume>, <fpage>132</fpage>–<lpage>144</lpage><pub-id pub-id-type="pmid">16563226</pub-id></mixed-citation>
</ref>
<ref id="B146">
<label>146.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Sternsdorf</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Bolger</surname><given-names>T.A.</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>R.M.</given-names></name> and <name name-style="western"><surname>Yao</surname><given-names>T.P.</given-names></name></person-group> (<year>2005</year>) <article-title>Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications</article-title>. <source/>Mol. Cell. Biol.
<volume>25</volume>, <fpage>8456</fpage>–<lpage>8464</lpage><pub-id pub-id-type="pmid">16166628</pub-id></mixed-citation>
</ref>
<ref id="B147">
<label>147.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shalizi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Gaudillière</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Stegmüller</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Shirogane</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ge</surname><given-names>Q.</given-names></name><etal>et al</etal>.</person-group> (<year>2006</year>) <article-title>A calcium-regulated MEF2 SUMOylation switch controls postsynaptic differentiation</article-title>. <source/>Science
<volume>311</volume>, <fpage>1012</fpage>–<lpage>1017</lpage><pub-id pub-id-type="pmid">16484498</pub-id></mixed-citation>
</ref>
<ref id="B148">
<label>148.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zündorf</surname><given-names>G.</given-names></name> and <name name-style="western"><surname>Reiser</surname><given-names>G.</given-names></name></person-group> (<year>2011</year>) <article-title>Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection</article-title>. <source/>Antioxid. Redox Signal.
<volume>14</volume>, <fpage>1275</fpage>–<lpage>1288</lpage><pub-id pub-id-type="pmid">20615073</pub-id></mixed-citation>
</ref>
<ref id="B149">
<label>149.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krumova</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Meulmeester</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Garrido</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tirard</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hsiao</surname><given-names>H. H.</given-names></name>, <name name-style="western"><surname>Bossis</surname><given-names>G</given-names></name><etal>et al</etal>.</person-group> (<year>2011</year>) <article-title>SUMOylation inhibits α-synuclein aggregation and toxicity</article-title>. <source/>J. Cell Biol.
<volume>194</volume>, <fpage>49</fpage>–<lpage>60</lpage><pub-id pub-id-type="pmid">21746851</pub-id></mixed-citation>
</ref>
<ref id="B150">
<label>150.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abeywardana</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Pratt</surname><given-names>M.R.</given-names></name></person-group> (<year>2015</year>) <article-title>Extent of inhibition of α synuclein aggregation in vitro by SUMOylation is conjugation site- and SUMO isoform-selective</article-title>. <source/>Biochem
<volume>54</volume>, <fpage>959</fpage>–<lpage>961</lpage><pub-id pub-id-type="pmid">25607946</pub-id></mixed-citation>
</ref>
<ref id="B151">
<label>151.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ronzitti</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Bucci</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Emanuele</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Leo</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Sotnikova</surname><given-names>T.D.</given-names></name>, <name name-style="western"><surname>Mus</surname><given-names>L.V.</given-names></name><etal>et al</etal>.</person-group> (<year>2014</year>) <article-title>Exogenous α-synuclein decreases raft partitioning of Cav2.2 channels inducing dopamine release</article-title>. <source/>J. Neurosci.
<volume>34</volume>, <fpage>10603</fpage>–<lpage>10615</lpage><pub-id pub-id-type="pmid">25100594</pub-id></mixed-citation>
</ref>
<ref id="B152">
<label>152.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>Y.M.</given-names></name>, <name name-style="western"><surname>Mouradian</surname><given-names>M.M.</given-names></name> and <name name-style="western"><surname>Chung</surname><given-names>K.C.</given-names></name></person-group> (<year>2011</year>) <article-title>Human polycomb protein 2 promotes α-synuclein aggregate formation through covalent SUMOylation</article-title>. <source/>Brain Res.
<volume>1381</volume>, <fpage>78</fpage>–<lpage>89</lpage><pub-id pub-id-type="pmid">21256122</pub-id></mixed-citation>
</ref>
<ref id="B153">
<label>153.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Wansleeben</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Miao</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Paschen</surname><given-names>W.</given-names></name> and <name name-style="western"><surname>Yang</surname><given-names>W.</given-names></name></person-group> (<year>2014</year>) <article-title>SUMO-2 is essential while SUMO3 is dispensable for mouse embryonic development</article-title>. <source/>EMBO Rep.
<volume>15</volume>, <fpage>878</fpage>–<lpage>885</lpage><pub-id pub-id-type="pmid">24891386</pub-id></mixed-citation>
</ref>
<ref id="B154">
<label>154.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Wen</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Moskowitz</surname><given-names>I.P.</given-names></name><etal>et al</etal>.</person-group> (<year>2011</year>) <article-title>Defective SUMOylation pathway directs congenital heart disease</article-title>. <source/>Birth Defects Res. A Clin. Mol. Teratol.
<volume>91</volume>, <fpage>468</fpage>–<lpage>476</lpage><pub-id pub-id-type="pmid">21563299</pub-id></mixed-citation>
</ref>
<ref id="B155">
<label>155.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>E.Y.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Segura</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Beketaev</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Xi</surname><given-names>Y.</given-names></name><etal>et al</etal>.</person-group> (<year>2015</year>) <article-title>Involvement of activated SUMO-2 conjugation in cardiomyopathy</article-title>. <source/>Biochim. Biophys. Acta
<volume>1852</volume>, <fpage>1388</fpage>–<lpage>1399</lpage><pub-id pub-id-type="pmid">25857621</pub-id></mixed-citation>
</ref>
<ref id="B156">
<label>156.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kho</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Jeong</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>J.G.</given-names></name>, <name name-style="western"><surname>Chaanine</surname><given-names>A.H.</given-names></name>, <name name-style="western"><surname>Kizana</surname><given-names>E.</given-names></name><etal>et al</etal>.</person-group> (<year>2011</year>) <article-title>SUMO-1-dependent modulation of SERCA2a in heart failure</article-title>. <source/>Nature
<volume>477</volume>, <fpage>601</fpage>–<lpage>605</lpage><pub-id pub-id-type="pmid">21900893</pub-id></mixed-citation>
</ref>
<ref id="B157">
<label>157.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>E.Y.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Moskowitz</surname><given-names>I.P.</given-names></name><etal>et al</etal>.</person-group> (<year>2012</year>) <article-title>Enhanced deSUMOylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>52</volume>, <fpage>638</fpage>–<lpage>649</lpage><pub-id pub-id-type="pmid">22155005</pub-id></mixed-citation>
</ref>
<ref id="B158">
<label>158.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mendler</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Braun</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Müller</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>) <article-title>The ubiquitin-like SUMO system and heart function from development to disease</article-title>. <source/>Circ. Res.
<volume>118</volume>, <fpage>132</fpage>–<lpage>144</lpage><pub-id pub-id-type="pmid">26837744</pub-id></mixed-citation>
</ref>
<ref id="B159">
<label>159.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>Y.J.</given-names></name> and <name name-style="western"><surname>Hallenbeck</surname><given-names>J.M.</given-names></name></person-group> (<year>2013</year>) <article-title>SUMO and ischemic tolerance</article-title>. <source/>Neuromol. Med.
<volume>15</volume>, <fpage>771</fpage>–<lpage>781</lpage></mixed-citation>
</ref>
<ref id="B160">
<label>160.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Henley</surname><given-names>J.M.</given-names></name></person-group> (<year>2014</year>) <article-title>Wrestling with stress: roles of protein SUMOylation and deSUMOylation in cell stress response</article-title>. <source/>IUBMB Life
<volume>66</volume>, <fpage>71</fpage>–<lpage>77</lpage><pub-id pub-id-type="pmid">24470405</pub-id></mixed-citation>
</ref>
<ref id="B161">
<label>161.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>M.K.</given-names></name>, <name name-style="western"><surname>Gulick</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Molkentin</surname><given-names>J.D.</given-names></name> and <name name-style="western"><surname>Robbins</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>) <article-title>SUMO E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes</article-title>. <source/>Circ. Res.
<volume>115</volume>, <fpage>721</fpage>–<lpage>729</lpage><pub-id pub-id-type="pmid">25097219</pub-id></mixed-citation>
</ref>
<ref id="B162">
<label>162.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maejima</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Sadoshima</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>) <article-title>SUMOylation: a novel protein quality control modifier in the heart</article-title>. <source/>Circ. Res.
<volume>115</volume>, <fpage>686</fpage>–<lpage>689</lpage><pub-id pub-id-type="pmid">25258400</pub-id></mixed-citation>
</ref>
<ref id="B163">
<label>163.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsuzaki</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Minami</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Tojo</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Honda</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Uchimura</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Saitoh</surname><given-names>H.</given-names></name><etal>et al</etal>.</person-group> (<year>2003</year>) <article-title>Serum response factor is modulated by the SUMO-1 conjugation system</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>306</volume>, <fpage>32</fpage>–<lpage>38</lpage><pub-id pub-id-type="pmid">12788062</pub-id></mixed-citation>
</ref>
<ref id="B164">
<label>164.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>X.H.</given-names></name> and <name name-style="western"><surname>Schwartz</surname><given-names>R.J.</given-names></name></person-group> (<year>2004</year>) <article-title>SUMO-1 modification activated GATA4-dependent cardiogenic gene activity</article-title>. <source/>J. Biol. Chem.
<volume>279</volume>, <fpage>49091</fpage>–<lpage>49098</lpage><pub-id pub-id-type="pmid">15337742</pub-id></mixed-citation>
</ref>
<ref id="B165">
<label>165.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Olson</surname><given-names>E.N.</given-names></name> and <name name-style="western"><surname>Schwartz</surname><given-names>R.J.</given-names></name></person-group> (<year>2007</year>) <article-title>Myocardin SUMOylation transactivates cardiogenic genes in pluripotent 10T1/2 fibroblasts</article-title>. <source/>Mol. Cell Biol.
<volume>27</volume>, <fpage>622</fpage>–<lpage>632</lpage><pub-id pub-id-type="pmid">17101795</pub-id></mixed-citation>
</ref>
<ref id="B166">
<label>166.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pal</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hartnett</surname><given-names>K.A.</given-names></name>, <name name-style="western"><surname>Nerbonne</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Levitan</surname><given-names>E.S.</given-names></name> and <name name-style="western"><surname>Aizenman</surname><given-names>E.</given-names></name></person-group> (<year>2003</year>) <article-title>Mediation of neuronal apoptosis by K<sub>V</sub>2.1-encoded potassium channels</article-title>. <source/>J. Neurosci.
<volume>23</volume>, <fpage>4798</fpage>–<lpage>4802</lpage><pub-id pub-id-type="pmid">12832499</pub-id></mixed-citation>
</ref>
<ref id="B167">
<label>167.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stapels</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Piper</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Stowell</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Xiong</surname><given-names>Z.G.</given-names></name><etal>et al</etal>.</person-group> (<year>2010</year>) <article-title>Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance</article-title>. <source/>Sci. Signal.
<volume>3</volume>, <fpage>ra15</fpage><pub-id pub-id-type="pmid">20197544</pub-id></mixed-citation>
</ref>
<ref id="B168">
<label>168.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rougier</surname><given-names>J.S.</given-names></name>, <name name-style="western"><surname>Albesa</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Abrie</surname><given-names>I.H.</given-names></name></person-group> (<year>2010</year>) <article-title>Ubiquitylation and SUMOylation of cardiac ion channels</article-title>. <source/>J. Cardiovasc. Pharmacol.
<volume>56</volume>, <fpage>22</fpage>–<lpage>28</lpage><pub-id pub-id-type="pmid">20224423</pub-id></mixed-citation>
</ref>
<ref id="B169">
<label>169.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.Q.</given-names></name> and <name name-style="western"><surname>Sarge</surname><given-names>K.D.</given-names></name></person-group> (<year>2008</year>) <article-title>SUMOylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies</article-title>. <source/>J. Cell Biol.
<volume>182</volume>, <fpage>35</fpage>–<lpage>39</lpage><pub-id pub-id-type="pmid">18606848</pub-id></mixed-citation>
</ref>
<ref id="B170">
<label>170.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Broers</surname><given-names>J.L.</given-names></name>, <name name-style="western"><surname>Ramaekers</surname><given-names>F.C.</given-names></name>, <name name-style="western"><surname>Bonne</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Yaou</surname><given-names>R.B.</given-names></name> and <name name-style="western"><surname>Hutchison</surname><given-names>C.J.</given-names></name></person-group> (<year>2006</year>) <article-title>Nuclear lamins: laminopathies and their role in premature ageing</article-title>. <source/>Physiol. Rev.
<volume>86</volume>, <fpage>967</fpage>–<lpage>1008</lpage><pub-id pub-id-type="pmid">16816143</pub-id></mixed-citation>
</ref>
<ref id="B171">
<label>171.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cartwright</surname><given-names>E.J.</given-names></name>, <name name-style="western"><surname>Mohamed</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Oceandy</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Neyses</surname><given-names>L.</given-names></name></person-group> (<year>2011</year>) <article-title>Calcium signaling dysfunction in heart disease</article-title>. <source/>Biofactors
<volume>37</volume>, <fpage>175</fpage>–<lpage>181</lpage><pub-id pub-id-type="pmid">21674639</pub-id></mixed-citation>
</ref>
<ref id="B172">
<label>172.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilkins</surname><given-names>B.J.</given-names></name> and <name name-style="western"><surname>Molkentin</surname><given-names>J.D.</given-names></name></person-group> (<year>2004</year>) <article-title>Calcium-calcineurin signaling in the regulation of cardiac hypertrophy</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>322</volume>, <fpage>1178</fpage>–<lpage>1191</lpage><pub-id pub-id-type="pmid">15336966</pub-id></mixed-citation>
</ref>
<ref id="B173">
<label>173.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernt</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Rangrez</surname><given-names>A.Y.</given-names></name>, <name name-style="western"><surname>Eden</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Jungmann</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Katz</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Rohr</surname><given-names>C.</given-names></name><etal>et al</etal>.</person-group> (<year>2016</year>) <article-title>SUMOylation-independent activation of Calcineurin-NFAT signaling via SUMO-2 mediates cardiomyocyte hypertrophy</article-title>. <source/>Sci. Rep.
<volume>6</volume>, <fpage>35758</fpage><pub-id pub-id-type="pmid">27767176</pub-id></mixed-citation>
</ref>
<ref id="B174">
<label>174.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woodcock</surname><given-names>E.A.</given-names></name> and <name name-style="western"><surname>Matkovich</surname><given-names>S.J.</given-names></name></person-group> (<year>2005</year>) <article-title>Cardiomyocytes structure, function and associated pathologies</article-title>. <source/>Int. J. Biochem. Cell Biol.
<volume>37</volume>, <fpage>1746</fpage>–<lpage>1751</lpage><pub-id pub-id-type="pmid">15950518</pub-id></mixed-citation>
</ref>
<ref id="B175">
<label>175.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meyer</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Schillinger</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Pieske</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Holubarsch</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Heilmann</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Posival</surname><given-names>H.</given-names></name><etal>et al</etal>.</person-group> (<year>1995</year>) <article-title>Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy</article-title>. <source/>Circulation
<volume>92</volume>, <fpage>778</fpage>–<lpage>784</lpage><pub-id pub-id-type="pmid">7641356</pub-id></mixed-citation>
</ref>
<ref id="B176">
<label>176.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Melchior</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Paschal</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Gerace</surname><given-names>L.</given-names></name></person-group> (<year>1993</year>) <article-title>Inhibition of nuclear protein import by nonhydrolyzable analogues of GTP and identification of the small GTPase Ran/TC4 as an essential transport factor</article-title>. <source/>J. Cell Biol.
<volume>123</volume>, <fpage>1649</fpage>–<lpage>1659</lpage><pub-id pub-id-type="pmid">8276887</pub-id></mixed-citation>
</ref>
<ref id="B177">
<label>177.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kho</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Jeong</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>J.G.</given-names></name>, <name name-style="western"><surname>Gorski</surname><given-names>P.A.</given-names></name>, <name name-style="western"><surname>Fish</surname><given-names>K.</given-names></name><etal>et al</etal>.</person-group> (<year>2015</year>) <article-title>Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure</article-title>. <source/>Nat. Commun.
<volume>7229</volume>, <fpage>1</fpage>–<lpage>11</lpage></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>